Page last updated: 2024-08-22

angiotensin ii and Hypertrophy, Left Ventricular

angiotensin ii has been researched along with Hypertrophy, Left Ventricular in 331 studies

Research

Studies (331)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	87 (26.28)	18.2507
2000's	140 (42.30)	29.6817
2010's	90 (27.19)	24.3611
2020's	14 (4.23)	2.80

Authors

Authors	Studies
Billoff, S; Bode-Böger, SM; Bornstein, SR; Deussen, A; Jarzebska, N; Kolouschek, A; Kopaliani, I; Mangoni, AA; Martens-Lobenhoffer, J; Ragavan, VN; Rodionov, RN; Weiss, N	1
Ding, XL; Qian, HB; Xue, DJ; Yang, FM; Yuan, QQ; Zhu, YZ	1
Bizé, A; Boucher, P; Brehat, J; Chiaroni, PM; Corboz, D; Dai, J; de Pommereau, A; Denormandie, P; Gallet, R; Germain, S; Ghaleh, B; Lacampagne, A; Marbán, E; Mouri, N; Pallot, G; Panel, M; Sambin, L; Su, JB; Teiger, E; Thery, G	1
Cai, L; Hui, X; Li, S; Li, X; Liu, J; Liu, X; Shu, S; Wang, F; Xia, H; Yang, Y	1
de Boer, RA; Koonen, DPY; Lindtstedt, EL; Michaëlsson, E; Piek, A; Schouten, EM; Silljé, HHW	1
Bai, C; Chen, J; Chen, L; Ge, J; Li, H; Liu, R; Liu, T; Song, L; Sun, Y; Wen, H; Xiao, N; Xu, H; Zhang, Y	1
Chen, Y; Du, J; Jia, MZ; Liu, Y; Ning, ZP; Qi, YF; Ren, JL; Tang, CS; Yu, YR; Zhang, LS; Zhang, YR	1
Ding, Y; Fu, X; Liu, F; Lou, Y; Wen, H; Yang, L; Yang, Q; Zhang, J; Zhang, L	1
Dong, Z; Ge, J; Hu, K; Li, W; Sun, A; Sun, X; Wu, J; Yin, L	1
Baker, AH; Borthwick, G; Boswell, L; Dweck, MR; Gray, GA; Jansen, MA; Kwiecinski, J; Lennen, RJ; Newby, DE	1
Boogerd, CJ; de Boer, RA; Dokter, MM; Lam, CSP; Markousis-Mavrogenis, G; Meems, LMG; Schouten, EM; Silljé, HHW; Voors, AA; Westenbrink, BD; Withaar, C	1
Du, W; Hu, J; Li, W; Li, Y; Liu, F; Wang, X; Xu, L; Yang, L; Yue, Q; Zhao, R	1
Bereshchenko, O; Berrino, L; Bruscoli, S; Cappetta, D; Cianflone, E; Cozzolino, A; De Angelis, A; Flamini, S; Gagliardi, A; Rafaniello, C; Riccardi, C; Ricci, E; Ronchetti, S; Rossi, F; Urbanek, K	1
Chen, X; Chen, Y; Cheng, Y; Chu, J; Li, J; Lin, X; Liu, L; Peng, J; Shen, A; Shen, Z; Wu, M; Wu, X	1
Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C	1
Chai, D; Chen, X; Chu, Y; Du, H; Lin, J; Lin, X; Liu, J; Ma, K; Ruan, Q; Xie, H; Xu, C; Zeng, J; Zhang, H; Zhang, Y	1
Fukamizu, A; Ho, L; Imai, Y; Ishida, J; Ito, H; Kadowaki, A; Kimura, A; Kuba, K; Penninger, JM; Reversade, B; Sato, C; Sato, T; Watanabe, H; Yamaguchi, T	1
Hays, TT; Ma, B; Qiu, H; Stoll, S; Zhou, N	1
Chen, X; Cheng, YW; Jin, HY; Oudit, GY; Penninger, JM; Song, B; Wang, W; Xu, YL; Zhang, ZZ; Zhong, JC	1
Cooke, JP; Entman, ML; Jo, J; Kaelber, JT; Kim, E; Kim, J; Lai, L; Lee, HK; Nam, D; Reineke, EL; Suh, JH; Taffet, GE	1
Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Liu, B; Liu, CP; Piao, ZH; Ryu, Y; Sun, S	1
Liu, D; Nie, W; Shi, K; Xie, D; Yang, P; Yu, B; Zhang, H	1
Aisicovich, M; García, SI; Landa, MS; Peres Diaz, LS; Pirola, CJ; Schuman, ML; Toblli, JE	1
Baicu, C; Chinnakkannu, P; Gaspar, JA; Hoffman, S; Kuppuswamy, D; Mukherjee, R; Panneerselvam, S; Pleasant-Jenkins, D; Reese, C; Tourkina, E	1
Bastacky, SI; Jackson, EK; Salah, E; Tofovic, SP	1
Cai, L; Chen, Y; Feng, X; Han, C; Jin, L; Li, C; Li, Y; Mu, J; Yan, X; Yao, Q; Zhang, D; Zhao, R	1
Andrades, ME; Biolo, A; Caetano, DSL; Clausell, N; Leitão, SAT; Lopes, A; Nascimento, TG; Pinto, GH; Rohde, LEP; Soares, DDS	1
Cho, S; Heo, D; Jeong, J; Lee, J; Lee, ME; Lim, S; Park, S; Seo, M; Yang, J	1
Benedict, C; Cheng, Z; Cimini, M; de Lucia, C; Garikipati, VNS; Goukassian, DA; Kishore, R; Koch, WJ; Lucchese, AM; Roy, R; Truongcao, MM; Wang, C	1
Ihm, CG; Jeong, KH; Jung, SW; Kim, DJ; Kim, DO; Kim, JS; Kim, YG; Lee, SH; Lee, SY; Lee, TW; Lee, YH; Moon, JY; Park, SH; Sohn, IS; Song, SJ	1
Gopi, V; Parthasarathy, A; Umadevi, S; Vellaichamy, E	1
Gheissari, A; Merrikhi, A; Pirpiran, M; Sabri, M	1
Dai, J; Fang, Y; Gao, L; Ma, ZG; Tang, QZ; Wu, QQ; Xu, M; Yang, Z; Zong, J	1
Chen, M; Chen, ZW; Gao, HW; Liu, JL; Long, ZJ; Wang, YJ	1
Bhuiyan, MS; Fukunaga, K; Tagashira, H	1
Guo, XF; Jiang, H; Liu, GL; Lv, YJ; Qiao, Y; Ren, M; Wang, B; Yan, L; Zhang, JD	1
Higashimori, M; Ikeya, Y; Ishii, R; Kaneko, M; Komuro, I; Mano, T; Miwa, T; Ohtani, T; Omori, Y; Saito, Y; Sakata, Y; Takeda, Y; Tamaki, S; Tsukamoto, Y; Yamamoto, K	1
Guan, G; Ma, A; Shao, L; Tian, G; Wang, J; Wang, Y; Zhang, Y	1
Brouns, AE; Brouwers, O; Daniels, A; Derks, WJ; Janssen, BJ; Munts, C; Schalkwijk, CG; van Bilsen, M; van der Vusse, GJ; van Nieuwenhoven, FA	1
Abdureyim, S; Amat, N; Amat, R; Hoxur, P; Kijjoa, A; Mamut, D; Osman, Z	1
Chen, G; He, QY; Pan, SF; Pan, SQ; Shen, C; Zhang, XM	1
Basu, R; Fan, D; Kandalam, V; Kassiri, Z; Lee, J; Oudit, GY; Patel, V; Takawale, A; Wang, X	1
Chen, Q; Huang, D; Huang, S; Lei, W; Pang, L	1
Heymans, S; Westermann, D	1
Cardin, S; Deschepper, CF; Jeidane, S; Picard, S; Praktiknjo, S; Reudelhuber, TL; Scott-Boyer, MP	1
Du, J; Han, QY; Jiang, X; Li, HH; Liu, Y; Miao, J; Song, L; Tian, C; Wang, AW; Wang, HX; Xia, YL; Yu, L	1
Lu, GM; Zheng, H	1
Gu, GL; Xu, XL; Yang, QY; Zeng, RL	1
Chen, C; He, Z; Hoopes, SL; Wang, DW; Wen, Z; Zeldin, DC; Zhang, X	1
Andrés, V; Díez, J; González-Gómez, C; Guzmán-Martínez, G; Maraver, A; Orbe, J; Rivera-Torres, J; Serrano, M; Villa-Bellosta, R	1
Ainscough, JF; Ball, SG; Drinkhill, MJ; Frentzou, GA; Turner, NA	1
Deng, L; Ding, F; Ding, Y; Shen, A; Yao, H; Ye, L; Zhang, L	1
Dong, X; Wang, X; Wei, L; Yin, Z; Zhang, L; Zhou, H	1
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA	1
Aoki, T; Ikeda, S; Kadomatsu, K; Kikuchi, N; Kurosawa, R; Miyata, S; Mukherjee, R; Nogi, M; Numano, K; Omura, J; Otsuki, T; Satoh, K; Satoh, T; Shimokawa, H; Spinale, FG; Sugimura, K; Sunamura, S; Suzuki, K; Tatebe, S	1
Ahmad, S; Alencar, A; da Silva, J; Ferrario, CM; Groban, L; Lin, MR; Sun, X; Wang, H; Zapata-Sudo, G	1
Asada, Y; Chosa, E; Funamoto, T; Hao, Y; Hatakeyama, K; Kato, J; Kitamura, K; Kurogi, S; Nakamura, M; Sakamoto, S; Sekimoto, T; Sekita-Hatakeyama, Y; Tsuruda, T; Udagawa, N	1
Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H	1
Bachner-Hinenzon, N; Ben-Zvi, D; Cao, X; Fisch, S; Gertler, A; Kachel, E; Kolodgie, F; Kotev Emeth, S; Lavee, J; Raanani, E; Savion, N; Schäfer, K; Schneiderman, J; Schoen, FJ; Simon, A; Solomon, G; Virmani, R	1
Du, YP; Peng, YG; Shi, GX; Shi, Y; Su, H; Sun, CF; Wang, SG; Wang, YK; Wen, T	1
Basu, R; Fan, D; Fernandez-Patron, C; Kassiri, Z; Oudit, GY; Patel, V; Samokhvalov, V; Seubert, JM; Shen, M; Takawale, A; Wang, X	1
Bin, J; Chen, Z; Hao, H; Huang, X; Kitakaze, M; Li, Q; Li, X; Liao, W; Liao, Y; Lin, H; Xie, J; Xuan, W	1
Baldus, S; Eickholt, C; Jungen, C; Klatt, N; Kuklik, P; Lau, D; Meyer, C; Muellerleile, K; Reitmeier, A; Schad, C; Schäffer, B; Scherschel, K; Schwedhelm, E; Steven, D; Wassilew, K; Willems, S; Yamamura, J; Zeller, T	1
Antonio, EL; Antunes, HK; de Mello, MT; Dos Santos, AA; Giampá, SQ; Koike, MK; Lee, KS; Mônico-Neto, M; Serra, AJ; Souza, HS; Tucci, PJ; Tufik, S	1
Alkhattabi, A; Fulford, L; Gao, X; Jiang, M; Jones, S; Karani, R; Koch, SE; Lasko-Roiniotis, VM; Lorenz, JN; Mann, A; Nieman, M; Robbins, N; Rubinstein, J; Worley, MC	1
Beker, DL; Dyck, JR; Hamza, SM; Masson, G; Matsumura, N; Robertson, IM; Soltys, CM; Sung, MM	1
Liu, CT; Liu, MY	1
Bond Lau, W; Du, J; Li, P; Li, Y; Li, Z; Ma, XL; Wang, C; Wu, Y; Zhang, C	1
Dohi, K; Ito, M; Kato, S; Nobori, T; Onishi, K; Takamura, T; Wada, H; Yamada, N; Yamanaka, T	1
Dai, Q; Dong, P; Huang, Q; Jia, N; Jin, W; Liu, S; Zhang, J	1
Montezano, AC; Touyz, RM	1
Blaxall, BC; Bonnin, P; Callebert, J; Debbabi, H; Doly, S; Jaffré, F; Launay, JM; Maroteaux, L; Mettauer, B; Monassier, L; Setola, V	1
Kaludercic, N; Paolocci, N; Reggiani, C	1
Fukumoto, Y; Rashid, M; Seto, M; Shimokawa, H; Tawara, S; Yano, K	1
Amann, K; Buness, A; Lutz, D; Maercker, C; Petersen, I; Ridinger, H; Rutenberg, C	1
Böhm, M; Werner, CM	1
Hirooka, Y; Ito, K; Sunagawa, K	1
Chen, G; Lin, H; Luo, X; Wang, Z; Xiao, J	1
Cho, HS; Kim, WK; Lee, J; Park, S	1
Bruneval, P; Campbell, DJ; Karam, H; Ménard, J; Mullins, JJ	1
Aro, J; Leskinen, H; Mustonen, E; Pikkarainen, S; Pohjolainen, V; Ruskoaho, H; Rysä, J	1
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T	1
Arranz, C; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA; Toblli, JE; Turyn, D; Veiras, LC	1
Hu, Z; Liu, Y; Ma, C; Shi, H; Wu, D; Zhou, J	1
Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H	1
Di Lorenzo, A; Kauser, K; Krieger, MH; Sessa, WC; Teutsch, C	1
Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y; Wu, Q	1
Basu, R; Byrns, S; Chow, FL; Guo, D; Kassiri, Z; Loibner, H; Oudit, GY; Penninger, JM; Schuster, M; Wang, XH; Zhong, J	1
Li, J; Tang, YB; Xie, ZZ	1
Díez, J; González, A; Ravassa, S	1
Chen, CX; Gao, JP; Gu, WL; Lv, J; Wan, Y; Wu, Q	1
Duan, HJ; He, LC; Zhan, YZ; Zhang, Y	1
Aro, J; Kerkelä, R; Leskinen, H; Ruskoaho, H; Rysä, J; Saiho, T; Serpi, R; Skoumal, R; Szokodi, I; Tóth, M; Ulvila, J	1
Casarini, DE; Cunha, T; Flues, K; Irigoyen, MC; Moraes-Silva, I; Moreira, ED; Mostarda, C; Paulini, J; Piratello, AC; Salemi, V; Sirvente, R; Souza, PR	1
Bian, Y; Cheng, J; Du, J; Jia, L; Li, H; Li, Y; Qi, G; Xiao, C	1
Sharma, PL; Singh, K; Singh, T	1
Burger, D; Carter, A; He, Y; Montezano, AC; Nishigaki, N; Touyz, RM	1
Essick, EE; Ghobrial, J; Ohashi, K; Ouchi, N; Pimentel, DR; Sam, F; Shibata, R; Wilson, RM	1
Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC	1
Hata, M; Sezai, A; Shiono, M; Soma, M; Unosawa, S; Wakui, S; Yoshitake, I	1
Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Koibuchi, N; Nako, H; Ogawa, H; Toyama, K; Yamamoto, E; Yasuda, O	1
Chagas, C; Groban, L; Jessup, JA; Lin, MS; Lindsey, SH; Wang, H	1
Yu, YS; Zheng, H	1
Fujisawa, G; Iwazu, Y; Kimura, M; Kobayashi, E; Kobayashi, T; Kusano, E; Masuda, T; Murakami, T; Muto, S; Nonaka-Sarukawa, M; Sasaki, N; Shimada, K; Shinohara, M; Watanabe, Y	1
Alves-Rodrigues, EN; de Castro, I; Furukawa, LN; Heimann, JC; Oliveira, IB; Rosa, KT; Souza, RM; Veras, MM	1
Lerch, R; Montessuit, C; Papageorgiou, I; Pedrazzini, T; Pellieux, C	1
Ghigo, A; Hirsch, E; Perino, A; Shah, AM; Zhang, M	1
Alenina, N; Bader, M; Campagnole-Santos, MJ; Guimarães, GG; Martins, AS; Motta, DF; Oliveira, ML; Pimenta-Velloso, EP; Santos, RA; Santos, SH	1
Berdeaux, A; Bizé, A; Chan, HL; Dubois-Randé, JL; Ghaleh, B; Hittinger, L; Melka, J; Michineau, S; Pongas, D; Rienzo, M; Sambin, L; Su, JB	1
Chumley, P; Duckworth, MW; Feng, W; Hua, P; Jaimes, D; Jaimes, EA; Rezonzew, G; Xing, D	1
Chen, S; Gardner, DG	1
Hu, JJ; Jia, W; Li, CY; Li, XH; Lu, JM; Tian, RB; Xiang, ZG	1
Lin, J; Lin, L; Peng, F; Tang, H	1
Beavers, M; Harshfield, GA; Kapuku, GK; Murro, DG	1
Ge, J; Guo, J; Jiang, G; Li, L; Wang, S; Wu, J; You, J; Zou, Y	1
Liu, Y; Wang, Y; Zhang, MS	1
Akahashi, Y; Ambartsumian, N; Horie, T; Inuzuka, Y; Iwanaga, Y; Kato, T; Kawashima, T; Kimura, T; Kobuke, K; Koshimizu, TA; Lukanidin, E; Miyazaki, S; Morooka, H; Niizuma, S; Ono, K; Sheikh, SP; Shioi, T; Takase, T; Tamaki, Y	1
Benito, B; Brugada, J; Gay-Jordi, G; Guash, E; Mont, L; Nattel, S; Serrano-Mollar, A	1
Fredersdorf, S; Grimm, D; Kossmehl, P; Kreutz, R; Paul, M; Rothermund, L; Schulze-Tanzil, G; Shakibaei, M	1
Eguchi, S; Frank, GD; Inagami, T; Kagiyama, S; Phillips, MI; Zhang, YC	1
Akinboboye, OO; Bergmann, SR; Chou, RL	1
Malik, RA	1
Devereux, RB; Dige-Petersen, H; Frandsen, E; Hermann, KL; Ibsen, H; Olsen, MH; Rokkedal, J; Wachtell, K	1
Bartek, J; Bartkova, J; Busk, PK; Christoffersen, TE; Haunsø, S; Hinrichsen, R; Latella, L; Sheikh, SP; Strøm, CC; Wulf-Andersen, L	1
Fleischmann, EH; Schmieder, RE	1
Anguita Sánchez, M	1
Liang, X; Sun, M; Xie, X; Yang, T; Yu, G; Zhao, S	1
Frohlich, ED; Varagic, J	1
Doggrell, SA	1
Chernova, NA; Fomicheva, OA; Ivanova, OV; Karpov, YA; Rogoza, AN; Sergakova, LM	1
deChâtel, R; Ilves, M; Kinnunen, P; Piuhola, J; Ruskoaho, H; Szokodi, I; Vuolteenaho, O	1
Amano, K; Chayama, K; Iba, O; Ishida, T; Kambe, M; Kurisu, S; Matsubara, H; Matsuura, H; Oshima, T; Ozono, R; Sugino, H; Teranishi, Y	1
Sugden, PH	1
Delles, C; Klingbeil, AU; Müller, HJ; Oehmer, S; Schmidt, BM; Schmieder, RE	1
Pinto, YM; Pokharel, S; Sharma, UC	1
Miao, CY; Su, DF; Yuan, WJ; Zhang, LM	1
Leunissen, JD; Londoño, C; Ramakers, C; Schoenmakers, M; van Opstal, JM; Vos, MA	1
Kaaja, R; Kokkonen, JO; Kovanen, PT; Kuoppala, A; Leskinen, HK; Liesmaa, I; Lindstedt, KA; Luodonpää, M; Ruskoaho, H; Rysä, J; Shiota, N	1
Adam, AG; Jaimes, EA; Raij, L; Zhou, MS	1
Sidorenko, BA; Ugriumova, MO	1
Harada, M; Kawakami, R; Kishimoto, I; Kuwahara, K; Nakagawa, Y; Nakanishi, M; Nakao, K; Ogawa, Y; Saito, Y; Takahashi, N	1
Bertolozzi, I; Boddi, M; Cecioni, I; Gensini, GF; Lumachi, C; Modesti, PA; Perna, AM; Vanni, S	1
Goens, MB; Kanagy, NL; Lund, AK; Walker, MK	1
Lu, N; Wang, MJ; Wang, YX; Yao, T; Zhu, YC; Zhu, YZ	1
Imaizumi, T; Kai, H; Koga, M; Kudo, H; Kuwahara, F; Tahara, N; Takemiya, K; Tokuda, K; Yamamoto, T; Yasukawa, H	1
Ilves, M; Leskinen, H; Luodonpää, M; Ruskoaho, H; Vuolteenaho, O	1
Cuspidi, C; Leonetti, G; Zanchetti, A	1
Cerbai, E; Mugelli, A	1
Cheng, J; Guo, H; Lee, JD; Shan, J; Ueda, T; Wang, J	1
Charo, IF; Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Ishibashi, T; Kitamoto, S; Kura, S; Ohtani, K; Sugaya, T; Takeshita, A; Tsuchihashi, M; Tsuzuki, T; Zhao, Q	1
Anderson, K; Angermann, CE; Barone, FC; Behr, TM; Berova, M; Coatney, RW; Sackner-Bernstein, JD; Willette, RN	1
Díez, J	1
Booz, GW	1
Akino, M; Denhardt, D; Jia, N; Kitabatake, A; Kon, S; Liu, L; Matsui, Y; Morimoto, J; Okamoto, H; Onozuka, H; Rittling, SR; Uede, T	1
De Champlain, J; Laplante, MA; Wu, R	1
McCarty, MF	2
Foldes, G; Lako-Futo, Z; Ruskoaho, H; Ruzicska, E; Sarman, B; Somogyi, A; Szenasi, G; Toth, M; Tulassay, Z; Wellmann, J	1
Kohno, M	1
Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q	1
Blankesteijn, WM; Bornstein, P; Cleutjens, JP; Crijns, HJ; Daemen, MJ; Debets, JJ; Duisters, R; Evelo, CT; Heymans, S; Janssen, BJ; Pinto, YM; Pokharel, S; Porter, JG; Schroen, B; Sharma, U; Smits, JF; van Leeuwen, RE	1
Boomsma, F; de Boer, RA; Flesch, M; Pinto, YM; Pokharel, S; Suurmeijer, AJ; van Gilst, WH; van Kampen, DA; van Veldhuisen, DJ	1
Bourassa, E; Falcón, BL; Katovich, MJ; Raizada, MK; Speth, RC; Stewart, JM; Sumners, C; Walter, G	1
Bohnemeier, H; Cleutjens, JP; Crijns, HJ; Paul, M; Pinto, YM; Pokharel, S; Schunkert, H; Sharma, UC; Tian, XL; van Geel, PP	1
Albornoz, F; Brown, NJ; Crandall, DL; Elokdah, H; Fogo, AB; Griffin, JP; Vaughan, DE; Weisberg, AD	1
Hirohashi, K; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J	1
Bricca, G; Cerutti, C; Kurdi, M; Randon, J	1
Grassi, G	1
Campbell, DJ; Esler, MD; Hastings, J; Kaye, DM; Lambert, E; Lambert, G; Schlaich, MP	1
Battegay, E; Zeller, A	1
Cai, YM; He, JG; Liao, XX; Liu, J; Ma, H; Wang, LC; Wang, LJ; Zeng, WT	1
Kawamura, N; Kawano, S; Kubota, T; Monden, Y; Sunagawa, K; Takeshita, A; Tsutsui, H	1
Blázovics, A; Rosta, K; Ruzicska, E; Somogyi, A; Tóth, M; Vér, A	1
Du, GY; Sun, XF; Wang, DQ; Wang, W; Zhao, DZ	1
Deschamps, AM; Spinale, FG	1
Boner, G; Brenner, BM; Cooper, ME; Crow, RS; de Zeeuw, D; Dickson, T; Kowey, PR; McCarroll, K; Parving, HH; Shahinfar, S	1
Goens, MB; Lund, AK; Nuñez, BA; Walker, MK	1
Bargetto, J; Jalil, JE; Lavandero, S; Ocaranza, MP; Palomera, C; Román, M	1
Cao, RH; Chen, SL; Du, YG; Lü, JY; Qiao, ZD; Wang, GP; Zhang, ZY	1
Alexander, D; Chinnaiyan, KM; McCullough, PA	1
Hernandez Schulman, I; Jaimes, EA; Pagano, PJ; Raij, L; Zhou, MS	1
Rossi, GP	1
Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H	1
deChâtel, R; Földes, G; Ilves, M; Karádi, I; Lakó-Futó, Z; Leprán, I; Ruskoaho, H; Sármán, B; Skoumal, R; Tóth, M; Vajda, S	1
Aubin, MC; Carrier, M; Perrault, LP; Shi, YF; Tardif, JC	1
Devereux, RB; Krauser, DG	1
Date, T; Kawai, M; Mochizuki, S; Seki, S; Shimizu, M; Taniguchi, I; Taniguchi, M; Yoshida, S	1
Hatano, M; Kinugawa, K; Kohmoto, O; Nagai, R; Takahashi, T; Usui, S; Yao, A	1
Hu, R; Xiao, MF; Zhou, D	1
Fry, CH; Gray, RP; Sheridan, DJ; Turner, MA	1
Rettig, R; Steckelings, UM; Unger, T	1
de Lanerolle, P; Gu, LZ; Han, YJ; Hu, WY; Piano, M	1
Aro, J; DeChâtel, R; Földes, G; Göoz, M; Lakó-Futó, Z; Leppäluoto, J; Papp, L; Ruskoaho, H; Sármán, B; Seres, L; Skoumal, R; Szokodi, I; Tóth, M; Vuolteenaho, O	1
Cingolani, HE; Ennis, IL	1
Coffman, TM; Crowley, SD	1
Bernstein, KE; Delafontaine, P; Reudelhuber, TL	1
Hautala, N; Majalahti, T; Nemer, M; Paradis, P; Pikkarainen, S; Ruskoaho, H; Sármán, B; Suo-Palosaari, M; Tokola, H; Vuolteenaho, O; Wang, J	1
He, W; Liu, JX; Xiong, XQ; Zhou, L; Zhou, Q	1
Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Matsumoto, T; Sumitomo, Y; Yagi, S; Yoshida, S	1
Chen, CX; Guo, J	1
Dart, AM; Du, XJ; Gao, XM; Gibbs, ME; Kiriazis, H; Lambert, G; Ming, Z; Moore, XL; Su, Y; Wang, K; Xu, Q	1
Akino, M; Matsui, Y; Okamoto, H; Onozuka, H; Tsutsui, H; Xu, Z	1
Baud, L; Bellocq, A; de Castro Keller, A; Haymann, JP; Letavernier, E; Mesnard, L; Perez, J	1
Backx, PH; Crackower, MA; Dawood, F; Kassiri, Z; Liu, PP; Liu, QC; Oudit, GY; Penninger, JM; Scholey, JW; Zhou, J	1
Akasaka, H; Kaneda, Y; Katsuya, T; Kikuchi, Y; Morishita, R; Nakagami, H; Ogihara, T; Rakugi, H; Saitoh, S; Shimamoto, K	1
Barauna, VG; Krieger, JE; Magalhaes, FC; Oliveira, EM	1
Ishiye, M; Nakashima, M; Uematsu, T; Umemura, K	1
Haudenschild, CC; Jacobs, AK; Landau, C	1
Peters, J	1
Appay, MD; Bariety, J; Heudes, D; Hinglais, N; Michel, JB; Nicoletti, A; Philippe, M; Sassy-Prigent, C	1
Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Saito, H; Tohse, N; Yokoshiki, H	1
Besse, P; Bonoron-Adèle, S; Gouverneur, G; Sempé, S; Stuyvers, B; Tariosse, L	1
Baird, A; Blair-West, JR; Denton, DA; Gonzales, AM; Logan, A; McBurnie, M; Weisinger, RS	1
Gohlke, P; Linz, W; Schölkens, BA; Unger, T; Wiemer, G	1
Dawson, D; Denver, E; Foyle, WJ; Pinkney, J; Sampson, MJ; Yudkin, JS	1
Di Micco, G; Ducceschi, V; Iacono, A; Russo, B; Sarubbi, B	1
Piano, MR	1
Pitt, B; Timmis, AD	1
Holmer, SR; Riegger, G; Schunkert, H	1
Kadowaki, T; Kojima, M; Komuro, I; Mizuno, T; Shiojima, I; Tobe, K; Ueki, K; Wang, Y; Yamazaki, T; Zou, Z	1
Drexler, H; Holtz, J; Meybrunn, M; Riede, UN; Schieffer, B; Seitz, S; Wirger, A	1
Fukuchi, S; Katoh, K; Mizuno, K; Niimura, S	1
Re, RN	1
Dahlöf, B	3
Black, MJ; Campbell, GR; Campbell, JH	1
Brilla, CG; Matsubara, LS; Weber, KT	1
Apstein, CS; Jackson, B; Lorell, BH; Schoen, FJ; Schunkert, H; Smits, JF; Tang, SS	1
Brunner, HR	1
Higaki, J; Higashimori, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T	1
Fujioka, Y; Higaki, J; Ikegami, H; Kawaguchi, N; Kobayashi, R; Mikami, H; Nagano, M; Nakamura, F; Ogihara, T; Onishi, S	1
Leenen, FH; Ruzicka, M; Skarda, V	1
Langenfeld, MR; Schmieder, RE	1
de Leeuw, PW; Schiffers, PM; Schreij, G; van Es, PN	1
Dominiczak, AF; Foy, CJ; Fraser, R; Harrap, SB; Lever, AF; Morton, JJ; Watt, GC	1
Bruckschlegel, G; Lorell, BH; Riegger, AJ; Schunkert, H; Weinberg, EO	1
Lederballe, O; Mørn, B; Pedersen, EB; Schroeder, AP; Sihm, I; Thygesen, K	1
Frohlich, ED; Nuñez, E; Prakash, O; Susic, D	1
Bruckschlegel, G; Della Bruna, R; Kurtz, A; Riegger, GA; Schunkert, H; Wolf, K	1
Batlouni, M	1
Frohlich, ED; Kaneko, K; Nunez, E; Susic, D	1
Friedrich, A; Gatzka, CD; Langenfeld, MR; Schmieder, RE; Schobel, HP; Weihprecht, H	1
Canova, CR	1
Doba, N; Hinohara, S; Kihara, Y; Tomiyama, H; Watanabe, G; Yoshida, H	1
Ashizawa, N; Do, YS; Giachelli, CM; Graf, K; Hsueh, WA; Meehan, WP; Nunohiro, T; Tuan, TL	1
Komuro, I; Shiojima, I; Yamazaki, T; Yazaki, Y	1
Brunner, HR; Morgan, T	1
Hisamatsu, Y; Kobayashi, S; Kohno, M; Matsuzaki, M; Obayashi, M; Ohkusa, T; Ryoke, T; Yamakawa, K; Yano, M	1
Dixon, IM; Hata, T; Makino, N; Sugano, M; Yanaga, T	1
Charlier, AA; Donckier, J; Hayashida, W; Pouleur, H; Van Mechelen, H	2
Lindpaintner, K; Raman, V; Rubattu, S; Volpe, M	1
Lerch, R; Montessuit, C	1
Bertram, JF; Black, MJ; Briscoe, T; Jackson, B; Johnston, CI	1
Groom, AS; Head, GA; Malpas, SC	1
Amant, C; Amouyel, P; Bauters, C; Bertrand, M; Hamon, M; Helbecque, N; Lablanche, JM; McFadden, E; Richard, F	1
Dahlöf, B; de Faire, U; Devereux, R; Fyhrquist, F; Hedner, T; Ibsen, H; Julius, S; Kjeldsen, S; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H	1
Maehle, BO; Stuhr, LE	1
Chen, X; Dai, Z; Hao, Y; Hui, Y; Jing, S	1
Lavie, CJ; Malik, FS; Mehra, MR; Milani, RV; Re, RN	1
Barragán Acea, A; Bosa Ojeda, F; de Armas Trujillo, D; Domínguez Rodríguez, A; García González, M; Lacalzada Almeida, J; Miralles Ibarra, JM	1
Burstow, DJ; Summers, KM; West, MJ; Wong, KK	1
Diglio, CA; Lancaster, WD; Marsh, JD; Ritchie, RH; Schiebinger, RJ	1
Diamond, JA; Gharavi, A; Phillips, RA	1
Hilgers, K; Langenfeld, MR; Schlaich, MP; Schmieder, RE; Schobel, HP	1
Akhter, SA; Iaccarino, G; Koch, WJ; Lefkowitz, RJ; Luttrell, LM; Rockman, HA	1
Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H	1
Leenen, FH; Yuan, B	1
Aubert, JF; Morgan, TO; Wang, Q	1
du Cailar, G; Herizi, A; Jover, B; Mimran, A; Pasquié, JL	1
Chien, KR; Clark, RG; Hongo, M; Mao, L; McKirnan, MD; Ross, J; Sentianin, EM; Tanaka, N; Won, W	1
Julius, S; Mann, J	1
Fujimura, A; Gotoh, E; Ishii, M; Iwamoto, T; Shionoiri, H; Sugimoto, K; Takasaki, I; Takizawa, T; Tokita, Y	1
Harder, S; Kenedi, P; Rietbrock, N; Schmidt, A; Thürmann, PA	1
Moreau, P	1
Chen, DG; Chen, SC; Hu, WY; Jin, XQ; Wang, HJ	1
Thürmann, PA	1
Hamada, M; Hashida, H; Hiwada, K	1
Diamond, JA; Gharavi, A; Henzlova, MJ; Machac, J; Phillips, RA; Roychoudhury, D; Travis, A	1
Delles, C; Jacobi, J; Schlaich, MP; Schmieder, RE; Schobel, HP	1
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF; Rieger, P	1
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF	1
Dumont, AS; McNeill, JH; Verma, S	1
Chen, DG; Chen, SC; Hu, WY; Rui, HB; Su, JZ; Wang, HJ; Wang, XY; Wu, KG; Xu, CS	1
Gottdiener, JS	1
Chen, X; Guan, JX; Luo, JD; Zhang, GP; Zhang, WW	1
Brink, M; Chrast, J; Delafontaine, P; Mitch, WE; Price, SR	1
Dell'Oro, R; Grassi, G; Mancia, G; Turri, C	1
Díez, J; Fortuño, MA; Ravassa, S	1
Capogrossi, MC; Emanueli, C; Madeddu, P; Maestri, R; Minasi, A; Olivetti, G; Salis, MB	1
Donaldson, F; Lang, D; Lewis, MJ; Mosfer, SI; Shakesby, A	1
González-Juanatey, JR	1
Brunner, HR; Gabbiani, G; Mazzolai, L; Nicoud, F; Nussberger, J; Pedrazzini, T	1
Anversa, P; Fiordaliso, F; Kajstura, J; Latini, R; Leri, A; Li, B; Liu, Y; Malhotra, A	1
Liang, Q; Tang, J; Wu, C; Zhou, Q	1
González-Juanatey, JR; Vallés Belsué, F	1
August, P; Leventhal, B; Suthanthiran, M	1
Díez, J; Laviades, C; Varo, N	1
Akers, WS; Cassis, LA; Cross, A; Dwoskin, LP; Speth, R	1
Eto, T; Imamura, T; Kato, J; Kitamura, K; Koiwaya, Y; Matsuo, T; Onitsuka, H; Tsumori, Y; Yamakawa, H	1
Díez, J; Fortuño, A; Fortuño, MA; González, A; López, B; Ravassa, S; Zalba, G	1
Camilión de Hurtado, MC; Cingolani, HE; Pérez, NG	1
Bravo, R; Fernández-Alfonso, MS; González, C; Ruiz-Gayo, M; Somoza, B	1
Hayashida, W; Inagaki, K; Iwanaga, Y; Kihara, Y; Sasayama, S; Yasaka, A	1
Burnett , JC; Grande, JP; Hart, CY; Housmans, PR; Meyer, DM; Redfield, MM; Tazelaar, HD	1
Gaffney, FA; Ichihara, S; Ichiki, T; Inagami, T; Price, E; Senbonmatsu, T	1
Deng, Z; Gao, M; Yan, C	1
Inagaki, K; Iwanaga, Y; Kataoka, K; Kihara, Y; Onozawa, Y; Sasayama, S; Yoneda, T	1
Cao, H; Ke, YS; Yang, T	1
Hanafusa, T; Katayama, Y; Komamura, K; Kuroda, YT; Miyatake, K; Mori, K; Shigemoto, S; Tatsumi, R; Yoneda, K	1
Liu, N; Zhang, J; Zhu, B	1
Asai, S; Fujii, M; Hayashi, M; Kinoshita, M; Kuwahara, K; Mabuchi, N; Maeda, K; Matsumoto, T; Nakao, K; Ohnishi, M; Saito, Y; Tanaka, H; Tsuji, T; Tsutamoto, T; Tsutsui, T; Wada, A; Wang, X; Yamamoto, T	1
Gálvez, A; Jalil, JE; Lavandero, S; Ocaranza, MP	1
Boddi, M; Cecioni, I; Colella, A; Coppo, M; Galanti, G; Michelucci, A; Modesti, PA; Neri Serneri, GG; Padeletti, L	1
Liang, X; Su, M; Xie, X; Yu, G; Zhao, S	1
Cai, H; Dong, Y; Hu, W	1
Guo, H; He, H; Jiang, C; Lu, D; Wang, J; Zhou, B	1
Moore, MA	1
Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML	1
Bouzegrhane, F; Thibault, G	1
Böhm, M; El-Armouche, A; Eschenhagen, T; Quattek, J; Seeland, U; Zolk, O	1
Unger, T	1
Andersen, SM; Gerdes, AM; McCune, SA; Mochizuki, S; Said, S; Tamura, T	1
Iwasaka, T; Masaki, H; Matsubara, H; Nishikawa, M; Nishiue, T; Shibasaki, Y	1
Ehmke, H; Faulhaber, J; Moser, L; Wiesner, RJ	1
Assem, M; Bernard, C; Ecarnot-Laubriet, A; Lecour, S; Moisant, M; Poirson-Bichat, F; Rochette, L; Solary, E; Teyssier, JR	1
Easthope, SE; Jarvis, B	1
Kahan, T; Nilsson, P	1
Ball, SG	1

Reviews

53 review(s) available for angiotensin ii and Hypertrophy, Left Ventricular

Article	Year
The therapeutic role of RAS blockade in chronic heart failure. Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Heart Failure; Humans; Hypertrophy, Left Ventricular; Renin-Angiotensin System	2008
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxidants & redox signaling, 2013, Mar-20, Volume: 18, Issue:9 Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Arrhythmias, Cardiac; Enzyme Activation; Fibroblasts; Fibrosis; Heart Failure; Humans; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Leukocytes; Membrane Glycoproteins; Mice; Models, Cardiovascular; Molecular Targeted Therapy; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Neovascularization, Pathologic; Oxidative Stress; Protein Isoforms; Reactive Oxygen Species; Subcellular Fractions	2013
Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart. The Journal of steroid biochemistry and molecular biology, 2013, Volume: 136 Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Ergocalciferols; Gene Expression; Hypertrophy, Left Ventricular; Intracellular Signaling Peptides and Proteins; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Myocardium; Myocytes, Cardiac; Receptors, Calcitriol	2013
Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy? Current cardiology reports, 2002, Volume: 4, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Meta-Analysis as Topic; Treatment Outcome	2002
[Prevention and treatment of congestive heart failure in diabetic patients]. Revista espanola de cardiologia, 2002, Volume: 55, Issue:10 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Meta-Analysis as Topic; Metoprolol; Prognosis; Propanolamines; Risk Factors; Time Factors	2002
Local cardiac renin-angiotensin system: hypertension and cardiac failure. Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:11 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Heart; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Organ Specificity; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vascular Resistance; Ventricular Remodeling	2002
Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cough; Diabetes Complications; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Receptor, Angiotensin, Type 1	2002
Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. Journal of cardiac failure, 2002, Volume: 8, Issue:6 Suppl Topics: Angiotensin II; Animals; Bradykinin; Endothelin-1; Humans; Hypertrophy, Left Ventricular; Myocytes, Cardiac; Protein Kinase C; Renin-Angiotensin System; Signal Transduction	2002
Left ventricular hypertrophy: virtuous intentions, malign consequences. The international journal of biochemistry & cell biology, 2003, Volume: 35, Issue:6 Topics: Activin Receptors, Type I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hypertrophy, Left Ventricular; Myocytes, Cardiac; Myosin Heavy Chains; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta	2003
[New perspectives of the use of angiotensin II receptor blocker]. Kardiologiia, 2003, Volume: 43, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Losartan; Receptors, Angiotensin	2003
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clinical and experimental pharmacology & physiology, 2003, Volume: 30, Issue:12 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Gene Expression; Humans; Hypertrophy, Left Ventricular; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ventricular Remodeling	2003
Left ventricular hypertrophy regression with antihypertensive treatment: focus on Candesartan. Blood pressure. Supplement, 2003, Volume: 2 Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Electrocardiography; Humans; Hypertrophy, Left Ventricular; Renin-Angiotensin System; Tetrazoles; Treatment Outcome	2003
Angiotensin II and the hypertensive heart: a role for the AT2 receptor? Journal of hypertension, 2004, Volume: 22, Issue:5 Topics: Angiotensin II; Animals; Humans; Hypertension; Hypertrophy, Left Ventricular; Receptor, Angiotensin, Type 2	2004
[Hypertension in patients with cardiac hypertrophy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors	2004
Left ventricular hypertrophy and angiotensin II receptor blocking agents. Current medicinal chemistry. Cardiovascular and hematological agents, 2005, Volume: 3, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Cardiotonic Agents; Clinical Trials as Topic; Humans; Hypertension; Hypertrophy, Left Ventricular; Models, Animal; Myocardium; Reactive Oxygen Species	2005
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Praxis, 2005, Apr-13, Volume: 94, Issue:15 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors	2005
Disruptions and detours in the myocardial matrix highway and heart failure. Current heart failure reports, 2005, Volume: 2, Issue:1 Topics: Angiotensin II; Disease Progression; Endothelin-1; Extracellular Matrix; Heart Failure; Humans; Hypertrophy, Left Ventricular; Integrins; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling	2005
Role of angiotensin II in the evolution of diastolic heart failure. Journal of clinical hypertension (Greenwich, Conn.), 2005, Volume: 7, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Mineralocorticoid Receptor Antagonists; Prognosis; Renal Insufficiency; Renin-Angiotensin System; Treatment Outcome	2005
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006
Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation, 2007, Mar-06, Volume: 115, Issue:9 Topics: Amiloride; Angiotensin II; Animals; Calcium Signaling; Carbonic Anhydrase II; Cardiomegaly; Cation Transport Proteins; Cells, Cultured; Endothelins; Heart Failure; Hormones; Humans; Hydrogen; Hydrogen-Ion Concentration; Hypertrophy, Left Ventricular; MAP Kinase Signaling System; Mice; Mitochondria, Heart; Models, Cardiovascular; Myocytes, Cardiac; Phosphorylation; Protein Processing, Post-Translational; Rabbits; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Signal Transduction; Sodium; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Stress, Mechanical; Swine	2007
In hypertension, the kidney rules. Current hypertension reports, 2007, Volume: 9, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Homeostasis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Resistance	2007
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Humans; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Transgenic; Promoter Regions, Genetic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vasoconstriction; Ventricular Myosins	2007
Molecular basis of human hypertension: the role of angiotensin. Bailliere's clinical endocrinology and metabolism, 1995, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensinogen; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Receptors, Angiotensin; Renin; Renin-Angiotensin System	1995
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacological reviews, 1995, Volume: 47, Issue:1 Topics: Amino Acid Sequence; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular System; Endothelium, Vascular; Humans; Hypertension; Hypertrophy, Left Ventricular; Kallikrein-Kinin System; Kinins; Molecular Sequence Data; Myocardial Ischemia; Nitric Oxide; Rabbits; Rats; Reperfusion Injury	1995
[Left ventricular myocardial hypertrophy: role of proto-oncogenes and ACE inhibition]. Cardiologia (Rome, Italy), 1994, Volume: 39, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cricetinae; Humans; Hypertrophy, Left Ventricular; Mesocricetus; Platelet-Derived Growth Factor; Proto-Oncogenes; Renin-Angiotensin System	1994
Cellular and signaling mechanisms of cardiac hypertrophy. The Journal of cardiovascular nursing, 1994, Volume: 8, Issue:4 Topics: Adenosine Triphosphate; Angiotensin II; Cardiovascular Diseases; Catecholamines; Gene Expression; Genes, fos; Genes, myc; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Patient Care Planning; Risk Factors; Signal Transduction; Thyroid Hormones	1994
Effects of ACE inhibitors on coronary atherosclerosis and restenosis. British heart journal, 1994, Volume: 72, Issue:3 Suppl Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Recurrence; Renin-Angiotensin System; Ventricular Dysfunction, Left	1994
[Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]. Zeitschrift fur Kardiologie, 1993, Volume: 82 Suppl 4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Bradykinin; Gene Expression Regulation; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Peptidyl-Dipeptidase A; Renin-Angiotensin System	1993
Myocardial hypertrophy, angiotensin, and ACE inhibitors. Angiology, 1993, Volume: 44, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Growth Substances; Humans; Hypertrophy, Left Ventricular; Renin-Angiotensin System	1993
The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hypertrophy, Left Ventricular; Renin-Angiotensin System	1993
Role of vasoactive peptides in blood pressure control. Journal of human hypertension, 1993, Volume: 7, Issue:4 Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Humans; Hypertrophy, Left Ventricular; Neuropeptide Y; Peptides; Renin-Angiotensin System	1993
Salt and left ventricular hypertrophy: what are the links? Journal of human hypertension, 1995, Volume: 9, Issue:11 Topics: Angiotensin II; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Renin-Angiotensin System; Sodium, Dietary; Sympathetic Nervous System	1995
Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Journal of human hypertension, 1995, Volume: 9 Suppl 5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Rats; Renin-Angiotensin System; Tetrazoles	1995
Left ventricular hypertrophy in mild essential hypertension. Its progression, prediction and treatment strategy. Japanese heart journal, 1996, Volume: 37, Issue:4 Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Disease Progression; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Norepinephrine	1996
The renin-angiotensin system and the heart: beyond 2000. Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Heart; Humans; Hypertrophy, Left Ventricular; Kidney; Rats; Renin; Renin-Angiotensin System; Risk Factors; Sodium	1996
[The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension]. Cardiologia (Rome, Italy), 1997, Volume: 42, Issue:1 Topics: Angiotensin II; Animals; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Renin-Angiotensin System	1997
[Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system]. Praxis, 1997, Feb-11, Volume: 86, Issue:7 Topics: Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Heart Failure; Humans; Hypertrophy, Left Ventricular; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Systole; Ventricular Dysfunction, Left	1997
Renin-angiotensin system: genes to bedside. American heart journal, 1997, Volume: 134, Issue:3 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiomyopathy, Dilated; Cardiovascular Diseases; Constriction, Pathologic; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Recurrence; Renin-Angiotensin System	1997
[Regression of left ventricular hypertrophy in hypertensive patients]. Revista espanola de cardiologia, 1997, Volume: 50 Suppl 4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular	1997
Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy. The case against an association. Advances in experimental medicine and biology, 1997, Volume: 432 Topics: Angiotensin II; Disease Susceptibility; Genotype; Humans; Hypertrophy, Left Ventricular; Models, Genetic; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin-Angiotensin System	1997
Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies. The Mount Sinai journal of medicine, New York, 1998, Volume: 65, Issue:2 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Risk Factors	1998
Endothelin in hypertension: a role for receptor antagonists? Cardiovascular research, 1998, Volume: 39, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Rats; Vascular Diseases; Vasoconstrictor Agents	1998
[Apoptosis in hypertensive cardiopathy]. Revista espanola de cardiologia, 1999, Volume: 52 Suppl 3 Topics: Adult; Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Heart Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Middle Aged; Myocardium; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tumor Suppressor Protein p53	1999
[Do angiotensin II receptor antagonists substitute angiotensin converting enzyme inhibitors in the treatment of high blood pressure?]. Revista espanola de cardiologia, 2000, Volume: 53, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetic Angiopathies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Vasoconstriction	2000
[Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists]. Medicina clinica, 2000, Volume: 114 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular; Receptors, Angiotensin; Risk Factors; Treatment Outcome	2000
Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Current hypertension reports, 2000, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Disease; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Linear Models; Prevalence; Stroke; Transforming Growth Factor beta; White People	2000
Left ventricular hypertrophy and angiotensin II antagonists. American journal of hypertension, 2001, Volume: 14, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Hormone Antagonists; Humans; Hypertension; Hypertrophy, Left Ventricular; Renin-Angiotensin System	2001
Improving the managed care of hypertension with angiotensin II antagonists. The American journal of the medical sciences, 2002, Volume: 323, Issue:1 Topics: Angiotensin II; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Managed Care Programs; Renin-Angiotensin System	2002
Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovascular research, 2002, Feb-01, Volume: 53, Issue:2 Topics: Angiotensin II; Animals; Animals, Newborn; Cell Differentiation; Cell Division; Cells, Cultured; Fibroblasts; Growth Substances; Humans; Hypertrophy, Left Ventricular; Models, Animal; Myocardium; Rabbits; Rats; Ventricular Remodeling	2002
The role of the renin-angiotensin system in the development of cardiovascular disease. The American journal of cardiology, 2002, Jan-24, Volume: 89, Issue:2A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertrophy, Left Ventricular; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System	2002
Candesartan cilexetil: an update of its use in essential hypertension. Drugs, 2002, Volume: 62, Issue:8 Topics: Adsorption; Age Factors; Aged; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Black People; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Renal Insufficiency; Tetrazoles; Treatment Outcome	2002
[Results from the LIFE study: promising effects of new hypertensive agents]. Lakartidningen, 2002, Apr-18, Volume: 99, Issue:16 Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Atenolol; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2002
Cardioprotection and ACE inhibitors. Clinical physiology and biochemistry, 1992, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Prognosis	1992

Trials

23 trial(s) available for angiotensin ii and Hypertrophy, Left Ventricular

Article	Year
Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model. Basic research in cardiology, 2023, 07-03, Volume: 118, Issue:1 Topics: Angiotensin II; Animals; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Stroke Volume; Swine; Ventricular Function, Left	2023
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study). Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2016, Jun-20, Volume: 22, Issue:3 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling	2016
Exaggerated hypertensive response to exercise in patients with diastolic heart failure. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:4 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Exercise; Exercise Test; Female; Heart Failure, Diastolic; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Quality of Life; Tetrazoles; Treatment Outcome	2008
Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Cross-Over Studies; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Leukocytes; Male; Pravastatin; Pyrroles; Quinolines; rac1 GTP-Binding Protein; ras Proteins; Rats; Rats, Inbred WKY; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction	2009
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:2 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Tetrazoles	2010
Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2011, Volume: 17, Issue:5 Topics: Aged; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Benzimidazoles; Biphenyl Compounds; Cardiac Surgical Procedures; Compliance; Drug Substitution; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome	2011
Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. Journal of the American College of Cardiology, 2002, Aug-21, Volume: 40, Issue:4 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Middle Aged; Tomography, Emission-Computed	2002
Prevention of cardiovascular morbidity with angiotension receptor blockade: life after LIFE. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19 Suppl 5 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Clinical Protocols; Diabetes Complications; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Morbidity; Risk	2002
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension]. Kardiologiia, 2002, Volume: 42, Issue:2 Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Receptors, Angiotensin; Telmisartan	2002
Functional relevance of aldosterone for the determination of left ventricular mass. The American journal of cardiology, 2003, Feb-01, Volume: 91, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Drug Interactions; Echocardiography; Humans; Hypertrophy, Left Ventricular; Male; Sodium Chloride, Dietary	2003
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia, 2005, Volume: 48, Issue:10 Topics: Aged; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Risk Assessment; Treatment Outcome	2005
Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy. Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:8 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Tetrazoles; Ventricular Remodeling	2006
Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:6 Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Female; Humans; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged; Radiography; Renal Artery; Renal Veins; Renin	1996
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. American journal of hypertension, 1997, Volume: 10, Issue:7 Pt 1 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Middle Aged; Research Design; Tetrazoles; Treatment Outcome	1997
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood pressure, 1998, Volume: 7, Issue:3 Topics: Aged; Amlodipine; Angiotensin II; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan	1998
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation, 1998, Nov-10, Volume: 98, Issue:19 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Tetrazoles; Treatment Outcome; Valine; Valsartan	1998
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan	1999
Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group. Current medical research and opinion, 1999, Volume: 15, Issue:1 Topics: Acrylates; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronary Circulation; Double-Blind Method; Enalapril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Thiophenes	1999
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. American journal of hypertension, 1999, Volume: 12, Issue:4 Pt 1 Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Echocardiography; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Reference Values; Regional Blood Flow; Vasoconstrictor Agents	1999
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation, 1999, Aug-10, Volume: 100, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diuretics; Drug Interactions; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Research Design; Tetrazoles; Valine; Valsartan	1999
Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension. The American journal of cardiology, 1999, Nov-18, Volume: 84, Issue:10A Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Data Interpretation, Statistical; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Patient Compliance; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome	1999
Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4 Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Collagen; Collagen Type I; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome	2000
Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron, 2002, Volume: 90, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Echocardiography; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Dialysis	2002

Other Studies

255 other study(ies) available for angiotensin ii and Hypertrophy, Left Ventricular

Article	Year
Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling. American journal of physiology. Heart and circulatory physiology, 2021, 11-01, Volume: 321, Issue:5 Topics: Amidohydrolases; Angiotensin II; Animals; Aorta; Blood Pressure; Disease Models, Animal; Enzyme Induction; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Transgenic; Time Factors; Vascular Remodeling; Vasodilation; Ventricular Function, Left; Ventricular Remodeling	2021
[Effect and mechanism of leonurine on pressure overload-induced cardiac hypertrophy in rats]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2022, Volume: 47, Issue:2 Topics: Angiotensin II; Animals; Cardiomegaly; Gallic Acid; Hypertrophy, Left Ventricular; Myocardium; Rats	2022
Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy. Journal of the American Heart Association, 2019, 08-20, Volume: 8, Issue:16 Topics: Angiotensin II; Animals; Aorta; Disease Models, Animal; Gene Knockout Techniques; Glycogen Synthase Kinase 3 beta; Humans; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Nuclear Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Transgenic; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling	2019
Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. Scientific reports, 2019, 12-10, Volume: 9, Issue:1 Topics: Angiotensin II; Animals; Diet, High-Fat; Disease Models, Animal; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Intra-Abdominal Fat; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Peroxidase; Severity of Illness Index; Thioxanthenes; Ventricular Remodeling	2019
Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice. Hypertension (Dallas, Tex. : 1979), 2020, Volume: 75, Issue:3 Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Collagen; Dependovirus; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Gene Expression Regulation; Gene Ontology; Genetic Vectors; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nuclear Receptor Subfamily 4, Group A, Member 2; Oleic Acid; Signal Transduction; Specific Pathogen-Free Organisms; Ventricular Remodeling	2020
Intermedin alleviates pathological cardiac remodeling by upregulating klotho. Pharmacological research, 2020, Volume: 159 Topics: Angiotensin II; Animals; Aorta, Abdominal; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cells, Cultured; Constriction; Disease Models, Animal; Fibrosis; Glucuronidase; Hypertrophy, Left Ventricular; Klotho Proteins; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Neuropeptides; Peptide Hormones; Phosphorylation; PPAR gamma; Rats, Sprague-Dawley; Signal Transduction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2020
Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Angiotensin II; Animals; Cells, Cultured; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Hesperidin; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling	2020
Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell death & disease, 2020, 07-30, Volume: 11, Issue:7 Topics: Aldehyde Dehydrogenase, Mitochondrial; Angiotensin II; Animals; Animals, Newborn; Aorta; Apoptosis; Base Sequence; Cardiotonic Agents; Constriction, Pathologic; Disease Models, Animal; Fibrosis; Heart Failure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Membrane Proteins; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Myocytes, Cardiac; Nuclear Respiratory Factor 1; Pressure; Rats; Signal Transduction; Thioctic Acid	2020
Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2020, 08-06, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Mice, Inbred C57BL; Myocardium; Time Factors; Ventricular Function, Left; Ventricular Remodeling	2020
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction. Cardiovascular research, 2021, 07-27, Volume: 117, Issue:9 Topics: Angiotensin II; Animals; Benzhydryl Compounds; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Female; Fibrosis; Gene Expression Regulation; Glucagon-Like Peptide-1 Receptor; Glucosides; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Incretins; Liraglutide; Mice, Inbred C57BL; Myocardium; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function, Left; Ventricular Remodeling	2021
C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload. Molecular medicine reports, 2021, Volume: 23, Issue:1 Topics: Angiotensin II; Animals; Aorta, Thoracic; Cardiomyopathies; Cell Line; Chemokines, CC; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hypertrophy, Left Ventricular; Immunoglobulin G; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptors, CCR5; Signal Transduction; Ventricular Remodeling	2021
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Cell Death; Diastole; Extracellular Matrix; Fibrosis; Hypertrophy; Hypertrophy, Left Ventricular; Inflammation; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Transcription Factors	2021
Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133 Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cell Line; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation; Gene Regulatory Networks; Hypertension; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction	2021
Acta medica Philippina, 2017, Volume: 51, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy	2017
Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling. Cardiovascular diabetology, 2021, 06-11, Volume: 20, Issue:1 Topics: Angiotensin II; Animals; Antifibrotic Agents; Benzhydryl Compounds; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Glucosides; Hypertrophy, Left Ventricular; Male; Myocardium; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2021
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovascular research, 2017, Jun-01, Volume: 113, Issue:7 Topics: Angiotensin II; Animals; Aorta; Apelin Receptors; Arterial Pressure; Cardiotonic Agents; Constriction; Disease Models, Animal; Fibrosis; Forkhead Box Protein M1; Gene Expression Regulation; Heart Failure; HEK293 Cells; Humans; Hypertension; Hypertrophy, Left Ventricular; Infusions, Subcutaneous; Ligands; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocardium; Peptide Hormones; Peptidyl-Dipeptidase A; Signal Transduction; Transfection; Ventricular Dysfunction, Left; Ventricular Function, Left	2017
The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload. Aging cell, 2017, Volume: 16, Issue:5 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cerebrovascular Disorders; Echocardiography; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Male; Mechanistic Target of Rapamycin Complex 1; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Pressure; Primary Cell Culture; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Valosin Containing Protein; Ventricular Remodeling	2017
Apelin Is a Negative Regulator of Angiotensin II-Mediated Adverse Myocardial Remodeling and Dysfunction. Hypertension (Dallas, Tex. : 1979), 2017, Volume: 70, Issue:6 Topics: Angiotensin II; Animals; Animals, Newborn; Apelin; Apoptosis; Cells, Cultured; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Ventricular Remodeling	2017
Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis. The Journal of biological chemistry, 2017, 12-29, Volume: 292, Issue:52 Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Heart Ventricles; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Nuclear Receptor Coactivator 2; Paracrine Communication; Transcriptional Activation; Vascular Endothelial Growth Factor A; Ventricular Remodeling	2017
Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Caspase 3; Cell Line; Gallic Acid; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide Synthase; p300-CBP Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Tumor Suppressor Protein p53	2018
Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Apoptosis; Atorvastatin; Cell Line; Cell Survival; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; MicroRNAs; Myocytes, Cardiac; Nerve Tissue Proteins; Rats, Sprague-Dawley; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling	2018
Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse. Journal of molecular and cellular cardiology, 2018, Volume: 124 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Susceptibility; Drinking; Fibrosis; Gene Expression Profiling; Hypertrophy, Left Ventricular; Immunohistochemistry; Mice; Myocardium; NIH 3T3 Cells; Phenotype; Rats; RNA Interference; RNA, Small Interfering; Thyrotropin-Releasing Hormone	2018
Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide. PloS one, 2018, Volume: 13, Issue:12 Topics: Angiotensin II; Angiotensins; Animals; Bone Marrow Cells; Capillary Permeability; Caveolin 1; Cell Movement; Fibrosis; Heart; Hypertrophy, Left Ventricular; Kidney; Male; Mice; Mice, Inbred C57BL; Myocardium; Peptide Fragments; Renin-Angiotensin System; Signal Transduction	2018
2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury. Journal of cardiovascular pharmacology, 2019, Volume: 73, Issue:3 Topics: 2-Methoxyestradiol; Angiotensin II; Animals; Blood Pressure; Fibrosis; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Kidney; Kidney Diseases; Male; Rats, Sprague-Dawley; Renin-Angiotensin System; Vascular Remodeling; Ventricular Function, Left; Ventricular Remodeling	2019
Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway. Cardiovascular research, 2020, 01-01, Volume: 116, Issue:1 Topics: Angiotensin II; Animals; Cell Line; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Humans; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Rats, Wistar; RNA Interference; Sialyltransferases; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling	2020
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system. American journal of physiology. Regulatory, integrative and comparative physiology, 2019, 06-01, Volume: 316, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Hypertrophy, Left Ventricular; Male; Mice, Inbred BALB C; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Ventricular Remodeling	2019
Radiological assessment of effectiveness of soluble RAGE in attenuating Angiotensin II-induced LVH mouse model using in vivo 9.4T MRI. Scientific reports, 2019, 06-11, Volume: 9, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertrophy, Left Ventricular; Linear Models; Magnetic Resonance Imaging, Cine; Male; Mice, Inbred C57BL; Receptor for Advanced Glycation End Products; Solubility	2019
Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction. JCI insight, 2019, 07-09, Volume: 5 Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomyopathies; Cell Survival; Cicatrix; Echocardiography; Fibrosis; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Membrane Glycoproteins; Mice; Monocytes; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Regeneration; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Remodeling	2019
Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats. American journal of physiology. Renal physiology, 2019, 09-01, Volume: 317, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Constriction; Disease Models, Animal; Estrogens; Female; Hypertension; Hypertrophy, Left Ventricular; Kidney Tubules; Macrophages; Male; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renal Artery; Renin-Angiotensin System; Sex Factors; Signal Transduction	2019
Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts. Indian journal of experimental biology, 2013, Volume: 51, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Down-Regulation; Gene Expression Regulation; Guanylate Cyclase; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Models, Biological; Myocardium; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Signal Transduction	2013
Possible correlation among echocardiographic measures, serum brain natriuretic peptide, and angiotensin II levels in hypertensive kidney transplanted children. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2013, Volume: 11, Issue:2 Topics: Adolescent; Angiotensin II; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Child; Child, Preschool; Circadian Rhythm; Cross-Sectional Studies; Echocardiography; Female; Humans; Hypertension, Renal; Hypertrophy, Left Ventricular; Kidney Transplantation; Male; Models, Cardiovascular; Natriuretic Peptide, Brain; Postoperative Complications; Risk Factors	2013
Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy. Herz, 2014, Volume: 39, Issue:3 Topics: Angiotensin II; Animals; Cardiotonic Agents; Cell Line; Cell Size; Cell Survival; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Isothiocyanates; Myocytes, Cardiac; NF-kappa B; Oncogene Protein v-akt; Rats; Sulfoxides; Treatment Outcome	2014
[Effects of sapindus saponins on inflammatory response mediated by Ang II/p38MAPK pathway and cardiac hypertrophy in spontaneously hypertensive rats]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2013, Volume: 38, Issue:7 Topics: Angiotensin II; Animals; Disease Models, Animal; Drugs, Chinese Herbal; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Sapindus; Saponins	2013
Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes. American journal of physiology. Heart and circulatory physiology, 2013, Oct-15, Volume: 305, Issue:8 Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anisoles; Calcium; Cardiomegaly; Cells, Cultured; Female; Heart; Hypertrophy, Left Ventricular; Inositol 1,4,5-Trisphosphate Receptors; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Narcotic Antagonists; Narcotics; Ovariectomy; Pentazocine; Propylamines; Rats; Rats, Wistar; Receptors, sigma; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sigma-1 Receptor; Vasoconstrictor Agents	2013
Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity. PloS one, 2013, Volume: 8, Issue:9 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiotonic Agents; Cell Line; Cell Size; Collagen; Gene Expression; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; PPAR gamma; Quercetin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transcription Factor AP-1	2013
A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading. American journal of physiology. Heart and circulatory physiology, 2013, Dec-01, Volume: 305, Issue:11 Topics: Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Cells, Cultured; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardium; Nephrectomy; Neuropeptides; Oxidative Stress; Pulmonary Edema; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Sodium Chloride, Dietary; Time Factors; Ventricular Function, Left	2013
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Collagen; Echocardiography; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Telmisartan; Transforming Growth Factor beta1	2014
Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice. PloS one, 2014, Volume: 9, Issue:1 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Cell Size; Diabetes Mellitus, Type 2; Dobutamine; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Myocardium; Myocytes, Cardiac; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling	2014
Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats. BMC complementary and alternative medicine, 2014, Jan-21, Volume: 14 Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; China; Dioscorea; Drugs, Chinese Herbal; Endothelin-1; Heart; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Kidney; Male; Malondialdehyde; Oxidative Stress; Phytotherapy; Rats, Sprague-Dawley; Rats, Wistar; Superoxide Dismutase	2014
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:4 Topics: Administration, Oral; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Isoflavones; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Remodeling	2014
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovascular research, 2014, Jul-15, Volume: 103, Issue:2 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Ventricular Remodeling	2014
Effects of emodin and irbesartan on ventricular fibrosis in Goldblatt hypertensive rats. Die Pharmazie, 2014, Volume: 69, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Cardiomyopathies; Collagen; Echocardiography; Emodin; Enzyme Inhibitors; Fibrosis; Heart Ventricles; Hydroxyproline; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Irbesartan; Male; Matrix Metalloproteinase 2; Myocardium; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tetrazoles	2014
Fibrosis or hypertrophy: let TIMPs decide. Cardiovascular research, 2014, Jul-15, Volume: 103, Issue:2 Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3	2014
Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 64, Issue:5 Topics: Angiotensin II; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Galectin 3; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardium; Osteopontin; Ventricular Remodeling	2014
Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. American journal of hypertension, 2015, Volume: 28, Issue:4 Topics: Angiotensin II; Animals; Calcineurin Inhibitors; Cytokines; Disease Models, Animal; Enzyme Activation; Fibrosis; Flavanones; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Lipoxygenase Inhibitors; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; NF-kappa B; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Ventricular Function, Left; Ventricular Remodeling	2015
Reduction of prohibitin expression contributes to left ventricular hypertrophy via enhancement of mitochondrial reactive oxygen species formation in spontaneous hypertensive rats. Free radical research, 2015, Volume: 49, Issue:2 Topics: Adenosine Triphosphate; Angiotensin II; Animals; Gene Expression Regulation; Gene Knockdown Techniques; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Prohibitins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Repressor Proteins; Ventricular Function	2015
The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients. Journal of translational medicine, 2015, Jan-16, Volume: 13 Topics: Angiotensin II; Bone Morphogenetic Protein 4; C-Reactive Protein; Cystatin C; Essential Hypertension; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Myocytes, Cardiac; Peptide Fragments; Polymorphism, Single Nucleotide; Procollagen; Protein Biosynthesis; RNA, Small Interfering; Transfection	2015
Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II. Cardiovascular research, 2015, Mar-01, Volume: 105, Issue:3 Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Cells, Cultured; Coculture Techniques; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Oxidative Stress; PPAR gamma; Rats; Signal Transduction; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling	2015
Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy. Journal of hypertension, 2015, Volume: 33, Issue:4 Topics: Amyloid Precursor Protein Secretases; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Dibenzazepines; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Signal Transduction	2015
A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice. Disease models & mechanisms, 2015, Aug-01, Volume: 8, Issue:8 Topics: Angiotensin II; Animals; Cell Death; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Macrophages; Male; Mice; Models, Cardiovascular; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Transgenes; Ventricular Dysfunction; Ventricular Remodeling	2015
Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients. Journal of translational medicine, 2015, Sep-05, Volume: 13 Topics: Adult; Angiotensin II; Animals; Apelin; Apelin Receptors; Blood Pressure; C-Reactive Protein; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Intercellular Signaling Peptides and Proteins; Ligands; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Prevalence; Rats; Receptors, G-Protein-Coupled; ROC Curve; Transfection	2015
Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway. Cardiovascular therapeutics, 2016, Volume: 34, Issue:1 Topics: Angiotensin II; Animals; Animals, Newborn; Aspirin; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Phosphorylation; Stroke Volume; Ventricular Function, Left	2016
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis. Journal of the American Heart Association, 2016, Jan-14, Volume: 5, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2016
Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:4 Topics: Angiotensin II; Animals; Animals, Newborn; Aortic Diseases; Basigin; Blood Proteins; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinases; Mechanotransduction, Cellular; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left	2016
Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats. Journal of cardiovascular pharmacology, 2016, Volume: 68, Issue:1 Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Chymases; Cromolyn Sodium; Crosses, Genetic; Diastole; Disease Models, Animal; Estrogens; Female; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Infusions, Subcutaneous; Mast Cells; Ovariectomy; Rats, Inbred BN; Rats, Inbred F344; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling	2016
Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:5 Topics: Angiotensin II; Animals; Disease Models, Animal; Follow-Up Studies; Heart Failure, Systolic; Hypertrophy, Left Ventricular; Male; Mice; Mice, Transgenic; Osteoprotegerin; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Remodeling	2016
Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling. Journal of the American Heart Association, 2016, 05-03, Volume: 5, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Aortic Valve Stenosis; Cell Proliferation; Cells, Cultured; Female; Humans; Hypertrophy, Left Ventricular; Leptin; Male; Mice; Mice, Knockout, ApoE; Middle Aged; Vascular Stiffness; Vasoconstrictor Agents; Ventricular Remodeling; Young Adult	2016
[Intervention of systolic pressure and left ventricular hypertrophy in rats under cold stress]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2016, Jun-20, Volume: 34, Issue:6 Topics: Angiotensin II; Animals; Benzazepines; Blood Pressure; Cold Temperature; Endothelin-1; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Inbred SHR; Stress, Physiological	2016
A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:4 Topics: ADAM17 Protein; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cells, Cultured; Disease Models, Animal; Disintegrins; Echocardiography, Doppler; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Proteolysis; Random Allocation; Rats; Ventricular Dysfunction, Left	2016
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin. Oncotarget, 2016, Oct-04, Volume: 7, Issue:40 Topics: Angiotensin II; Animals; beta Catenin; Cells, Cultured; Collagen; Dependovirus; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 4; Reperfusion Injury; RNA, Small Interfering; Transforming Growth Factor beta; Up-Regulation	2016
Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model. Physiological reports, 2016, Volume: 4, Issue:17 Topics: Angiotensin II; Animals; Autopsy; Fibrosis; Heart; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Models, Animal; Risk Factors; Sheep; Vasoconstrictor Agents; Ventricular Remodeling	2016
Paradoxical Sleep Deprivation Causes Cardiac Dysfunction and the Impairment Is Attenuated by Resistance Training. PloS one, 2016, Volume: 11, Issue:11 Topics: Angiotensin II; Animals; Corticosterone; Echocardiography, Doppler; Heart Rate; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Physical Conditioning, Animal; Rats; Rats, Wistar; Sleep Deprivation; Testosterone; Ventricular Remodeling	2016
Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation. Journal of hypertension, 2017, Volume: 35, Issue:3 Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Aorta; Calcium Channels; Constriction, Pathologic; Echocardiography; Heart; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Sarcolemma; TRPV Cation Channels; Up-Regulation; Vasoconstrictor Agents	2017
A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy. American journal of physiology. Heart and circulatory physiology, 2017, Mar-01, Volume: 312, Issue:3 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Electron Transport Complex I; Energy Metabolism; Enzyme Activators; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vasoconstrictor Agents	2017
Daily sesame oil supplementation attenuates local renin-angiotensin system via inhibiting MAPK activation and oxidative stress in cardiac hypertrophy. The Journal of nutritional biochemistry, 2017, Volume: 42 Topics: Angiotensin II; Animals; Enzyme Activation; Gene Expression Regulation; Genes, fos; Genes, jun; Hypertrophy, Left Ventricular; Male; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sesame Oil	2017
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Circulation, 2017, May-23, Volume: 135, Issue:21 Topics: Acetylation; Activating Transcription Factor 3; Angiotensin II; Animals; Binding Sites; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Histone Deacetylase 1; Histones; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; MAP Kinase Kinase 3; Mice, Knockout; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Promoter Regions, Genetic; Protein Kinase Inhibitors; Signal Transduction; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling	2017
Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling. Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Disease Models, Animal; Fibrosis; Granulocyte Colony-Stimulating Factor; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Myocardium; Osteopontin; Peptidyl-Dipeptidase A; Phosphorylation; Recombinant Proteins; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling	2009
Networking between systemic angiotensin II and cardiac mineralocorticoid receptors. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:6 Topics: Angiotensin II; Animals; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Receptors, Mineralocorticoid; Renin-Angiotensin System	2008
Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circulation research, 2009, Jan-02, Volume: 104, Issue:1 Topics: Adult; Angiotensin II; Animals; Cells, Cultured; Cytokines; ErbB Receptors; Female; Fibroblasts; Heart Failure; Heparin-binding EGF-like Growth Factor; Humans; Hypertrophy, Left Ventricular; Intercellular Signaling Peptides and Proteins; Isoproterenol; Male; Mice; Mice, Knockout; Mice, Transgenic; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Protein Interaction Mapping; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; src-Family Kinases	2009
Genes, geography and geometry: the "critical mass" in hypertrophic cardiomyopathy. The Journal of molecular diagnostics : JMD, 2009, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiomyopathy, Hypertrophic; Humans; Hypertrophy, Left Ventricular; Muscle Proteins; Mutation	2009
Expression and tissue localization of beta-catenin, alpha-actinin and chondroitin sulfate proteoglycan 6 is modulated during rat and human left ventricular hypertrophy. Experimental and molecular pathology, 2009, Volume: 86, Issue:1 Topics: Actinin; Angiotensin II; Animals; beta Catenin; Cell Cycle Proteins; Cells, Cultured; Chondroitin Sulfate Proteoglycans; Chromosomal Proteins, Non-Histone; Disease Models, Animal; Extracellular Matrix; Gene Expression Profiling; Humans; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Myocardium; Oligonucleotide Array Sequence Analysis; Osteonectin; Rats; Rats, Sprague-Dawley; Ventricular Remodeling; Versicans	2009
Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload. Circulation research, 2009, Apr-24, Volume: 104, Issue:8 Topics: Anesthesia, General; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain; Disease Models, Animal; Epinephrine; Epithelial Sodium Channels; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Infusions, Parenteral; Male; Mice; Mice, Inbred ICR; Microfilament Proteins; Myocardial Contraction; Norepinephrine; Protein Kinase Inhibitors; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Sodium Channel Blockers; Sodium Chloride, Dietary; Sympathetic Nervous System; Telemetry; Time Factors	2009
Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2009, Volume: 23, Issue:4-6 Topics: Angiotensin II; Animals; Base Sequence; Cell Line; Cyclic Nucleotide-Gated Cation Channels; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Hypertrophy, Left Ventricular; Immunoglobulins; Ion Channels; Molecular Sequence Data; Muscle Proteins; Myocytes, Cardiac; Potassium Channels; Promoter Regions, Genetic; Rats; RNA, Messenger; RNA, Small Interfering; Transcription, Genetic; Up-Regulation	2009
Regular exercise produced cardioprotective effects on rat's heart with hypertension induced by L-NAME administration. Clinical and experimental hypertension (New York, N.Y. : 1993), 2009, Volume: 31, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Disease Models, Animal; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Rats	2009
Prorenin contributes to angiotensin peptide formation in transgenic rats with rat prorenin expression targeted to the liver. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6 Topics: alpha 1-Antitrypsin; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Body Weight; Humans; Hypertension, Renal; Hypertrophy, Left Ventricular; Kidney; Liver; Male; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Inbred F344; Rats, Transgenic; Renin; Transgenes	2009
Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli. Blood pressure, 2009, Volume: 18, Issue:5 Topics: Angiotensin II; Animals; Animals, Newborn; Arginine Vasopressin; Calcium-Binding Proteins; Cells, Cultured; Endothelin-1; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Matrix Gla Protein; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger; Stress, Mechanical; Up-Regulation	2009
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:3 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dietary Carbohydrates; Disease Models, Animal; Fructose; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Rats, Sprague-Dawley; Ventricular Remodeling	2010
[Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2009, Volume: 34, Issue:24 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Enzyme-Linked Immunosorbent Assay; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Saponins; Triterpenes	2009
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro. Journal of hypertension, 2010, Volume: 28, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left	2010
Telmisartan regresses left ventricular hypertrophy in caveolin-1-deficient mice. Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:11 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caveolin 1; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 2; Telmisartan	2010
Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models. Fitoterapia, 2010, Volume: 81, Issue:7 Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Cardiovascular Agents; Collagen; Cyclic AMP; Drugs, Chinese Herbal; Endothelin-1; Fallopia japonica; Glucosides; Heart; Hypertrophy, Left Ventricular; Isoproterenol; Male; Mice; Myocytes, Cardiac; Organ Size; Phytotherapy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2010
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation, 2010, Aug-17, Volume: 122, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Cells, Cultured; CHO Cells; Collagen Type I, alpha 1 Chain; Cricetinae; Cricetulus; Down-Regulation; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Recombinant Proteins	2010
Genistein prevents myocardial hypertrophy in 2-kidney 1-clip renal hypertensive rats by restoring eNOS pathway. Pharmacology, 2010, Volume: 86, Issue:4 Topics: Angiotensin II; Animals; Collagen Type I; Cyclic GMP; Gene Expression Regulation; Genistein; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Ventricular Remodeling	2010
Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling? Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:6 Topics: Angiotensin II; Animals; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 10; Humans; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Protein Isoforms; Ventricular Remodeling	2010
[Effect of Chrysanthemum indicum on ventricular remodeling in rats]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2010, Volume: 33, Issue:7 Topics: Aldosterone; Angiotensin II; Animals; Chrysanthemum; Disease Models, Animal; Drugs, Chinese Herbal; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Isoproterenol; Male; Mice; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Thyroxine; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling	2010
[Effects of Bai-Chuan capsule on left ventricular hypertrophy and correlative indexes]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2010, Volume: 33, Issue:8 Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Apiaceae; Blood Pressure; Capsules; Captopril; Drugs, Chinese Herbal; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Radioimmunoassay; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY	2010
Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:4 Topics: Angiotensin II; Animals; Blotting, Western; Echocardiography; Electrophoretic Mobility Shift Assay; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor	2011
Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats. Clinics (Sao Paulo, Brazil), 2010, Volume: 65, Issue:12 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carotid Sinus; Collagen; Denervation; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System	2010
Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent. Cardiovascular toxicology, 2011, Volume: 11, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Hydralazine; Hypertrophy, Left Ventricular; Inflammation; Inflammation Mediators; Infusion Pumps; Leukocyte Common Antigens; Male; Mice; Mice, Inbred C57BL; Monocytes; Myofibroblasts; Random Allocation	2011
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy. Therapeutic advances in cardiovascular disease, 2011, Volume: 5, Issue:3 Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dyslipidemias; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Lipids; Nitrates; Nitrites; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left; Ventricular Pressure	2011
Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts. Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:8 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Biphenyl Compounds; Blood Pressure; Cell-Derived Microparticles; Cells, Cultured; Endothelial Cells; Hypertrophy, Left Ventricular; Irbesartan; Male; Membrane Microdomains; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; NADPH Oxidases; Platelet Endothelial Cell Adhesion Molecule-1; Protein Kinase Inhibitors; Reactive Oxygen Species; rho-Associated Kinases; Signal Transduction; Tetrazoles; Vascular Cell Adhesion Molecule-1	2011
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3 Topics: Adiponectin; AMP-Activated Protein Kinases; Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Genes, Reporter; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidants; Oxidative Stress; Phosphorylation; Rats; Reactive Oxygen Species; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Ventricular Remodeling	2011
Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:3 Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Nitrates; Nitrites; Pyrroles; Random Allocation; Swine; Vasodilation; Ventricular Dysfunction, Left	2011
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Biphenyl Compounds; Blood Pressure; Blotting, Western; Capillaries; Cells, Cultured; Cyclic N-Oxides; Endothelial Cells; Heart Diseases; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Irbesartan; MAP Kinase Kinase Kinase 5; Myocardial Ischemia; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Spin Labels; Superoxides; Tetrazoles; Ultrasonography; Vascular Endothelial Growth Factor A	2012
Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. Cardiovascular research, 2012, Apr-01, Volume: 94, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cardiotonic Agents; Cell Line; Collagen; Cyclopentanes; Echocardiography, Doppler; Estrogens; Female; Gene Expression Regulation; Genotype; Hypertrophy, Left Ventricular; Injections, Subcutaneous; Mice; Myocytes, Cardiac; NADPH Oxidase 4; NADPH Oxidases; Natriuretic Peptide, Brain; Ovariectomy; Phenotype; Quinolines; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2012
Chronic hydrogen-rich saline treatment reduces oxidative stress and attenuates left ventricular hypertrophy in spontaneous hypertensive rats. Molecular and cellular biochemistry, 2012, Volume: 365, Issue:1-2 Topics: Angiotensin II; Animals; Antioxidants; Catalase; Cytokines; Electron Transport Chain Complex Proteins; Glutathione Peroxidase; Glutathione Transferase; Heart Ventricles; Hemodynamics; Hydrogen; Hypertension; Hypertrophy, Left Ventricular; Male; Malondialdehyde; Mitochondria, Heart; NADPH Oxidases; NF-kappa B; Oxidative Stress; Peroxynitrous Acid; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Sodium Chloride; Superoxide Dismutase	2012
Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. American journal of physiology. Heart and circulatory physiology, 2012, May-01, Volume: 302, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Hypertrophy; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocytes, Cardiac; Neovascularization, Physiologic; Olmesartan Medoxomil; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Tetrazoles; Thrombospondin 1; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left	2012
Salt intake during pregnancy alters offspring's myocardial structure. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; Peptidyl-Dipeptidase A; Potassium; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary	2013
Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice. American journal of physiology. Heart and circulatory physiology, 2012, May-01, Volume: 302, Issue:9 Topics: Angiotensin II; Angiotensinogen; Animals; Diet, High-Fat; Dietary Fats; Fatty Acids; Heart Failure; Hypertrophy, Left Ventricular; Lipid Metabolism; Male; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Oxidation-Reduction; Palmitates; Triglycerides; Ventricular Remodeling	2012
Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice. Peptides, 2012, Volume: 38, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Collagen; Collagen Type I; Collagen Type III; Gene Expression Regulation; Heart; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Peptide Fragments; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Remodeling	2012
Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs. Basic research in cardiology, 2012, Volume: 107, Issue:6 Topics: Angiotensin II; Animals; Diastole; Female; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Myocardial Contraction; Swine; Ventricular Function, Left	2012
Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:5 Topics: Amino Acid Sequence; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Fibrosis; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Inflammation; Ki-67 Antigen; Kidney; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutation; NADPH Oxidase 4; NADPH Oxidases; Peptides; Proto-Oncogene Protein c-ets-1; Reverse Transcriptase Polymerase Chain Reaction	2012
Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways. Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:6 Topics: Angiotensin II; Animals; Antioxidants; Collagen; Disulfides; Fibrosis; Glutamate-Cysteine Ligase; Hemodynamics; Hypertrophy, Left Ventricular; Male; NF-E2-Related Factor 2; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sulfinic Acids	2012
Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. International journal of molecular medicine, 2012, Volume: 30, Issue:6 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Collagen; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke Volume; Transforming Growth Factor beta1; Ultrasonography	2012
Aldosterone contributes to elevated left ventricular mass in black boys. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:4 Topics: Adolescent; Age Factors; Aldosterone; Analysis of Variance; Angiotensin II; Biomarkers; Black or African American; Blood Pressure; Body Mass Index; Female; Georgia; Humans; Hypertrophy, Left Ventricular; Male; Natriuresis; Renin-Angiotensin System; Risk Factors; Sex Factors; Up-Regulation; Young Adult	2013
Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. Journal of cardiovascular pharmacology, 2013, Volume: 61, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium-Binding Proteins; Dipeptides; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Imidazoles; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Notch1; Tetrazoles; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling	2013
Nebivolol treatment improves resistant arterial function and reduces ventricular hypertrophy and angiotensin II in spontaneously hypertension rats. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2013, Volume: 14, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Body Weight; Endothelin-1; Ethanolamines; Femoral Artery; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Nebivolol; Nitroprusside; Norepinephrine; Rats; Rats, Inbred SHR; Renal Artery; Renin-Angiotensin System; Systole; Vascular Resistance	2013
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. Journal of molecular and cellular cardiology, 2013, Volume: 57 Topics: Angiotensin II; Animals; Cell Proliferation; Collagen; Connective Tissue Growth Factor; Fibrosis; Gene Expression Regulation; Gene Knockout Techniques; Heart Failure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myofibroblasts; Natriuretic Peptide, Brain; NIH 3T3 Cells; Rats; Rats, Inbred Dahl; S100 Calcium-Binding Protein A4; S100 Proteins; Transcriptome; Tumor Suppressor Protein p53	2013
Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PloS one, 2013, Volume: 8, Issue:2 Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Fibrosis; Hypertrophy, Left Ventricular; Losartan; Male; Myocardium; Physical Conditioning, Animal; Rats; Rats, Wistar; RNA, Messenger	2013
Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. American journal of hypertension, 2002, Volume: 15, Issue:7 Pt 1 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Blood Pressure; Blotting, Western; Chondroitin Sulfate Proteoglycans; Collagen Type I; Extracellular Matrix; Gene Expression; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; Organ Size; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Ventricular Function, Left	2002
Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation, 2002, Aug-20, Volume: 106, Issue:8 Topics: Angiotensin II; Animals; Blood Pressure; ErbB Receptors; Hypertension; Hypertrophy, Left Ventricular; Kinetics; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Sprague-Dawley	2002
No morbidity-mortality. Commentary. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19 Suppl 5 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Morbidity; Patient Selection	2002
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. American heart journal, 2002, Volume: 144, Issue:3 Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood Vessels; Cardiovascular Physiological Phenomena; Carotid Arteries; Echocardiography; Epinephrine; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Smooth, Vascular; Plethysmography, Impedance; Regression Analysis; Vascular Resistance; Ventricular Remodeling	2002
Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovascular research, 2002, Volume: 56, Issue:1 Topics: Angiotensin II; Animals; Blotting, Western; Caenorhabditis elegans Proteins; Carrier Proteins; Cells, Cultured; Cyclin D1; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinases; Cyclins; Helminth Proteins; Hypertrophy, Left Ventricular; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction	2002
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan. Chinese medical journal, 2002, Volume: 115, Issue:9 Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Fibrosis; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Losartan; Myocardium; Rats; Rats, Inbred SHR	2002
Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Contraction; Organ Culture Techniques; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; RNA, Messenger; Stress, Mechanical; Sulfonamides; Tetrazoles	2003
Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:1 Topics: Angiotensin II; Animals; Bradykinin; Coronary Vessels; Extracellular Space; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Kallikreins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Angiotensin II and AT1 receptor in hypertrophied ventricles and aortas of sinoaortic-denervated rats. Acta pharmacologica Sinica, 2003, Volume: 24, Issue:8 Topics: Angiotensin II; Animals; Aorta; Denervation; Heart Ventricles; Hypertrophy; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Sinoatrial Node	2003
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog. Cardiovascular research, 2003, Aug-01, Volume: 59, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Bradycardia; Chymases; Dose-Response Relationship, Drug; Female; Heart Block; Humans; Hypertrophy, Left Ventricular; Irbesartan; Male; Peptidyl-Dipeptidase A; Phenethylamines; Potassium Channel Blockers; Serine Endopeptidases; Sulfonamides; Tetrazoles; Torsades de Pointes	2003
Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure. Journal of hypertension, 2003, Volume: 21, Issue:9 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Disease Models, Animal; Echocardiography; Fibrosis; Gene Expression; Heart Failure; Hypertrophy, Left Ventricular; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Vasoconstrictor Agents	2003
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Isoprostanes; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride; Superoxides; Tetrazoles; Up-Regulation; Vasodilation	2003
Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation. Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:10 Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Gene Expression; Hypertrophy, Left Ventricular; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; Natriuretic Peptide, Brain; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fos; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents	2003
Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:1 Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiac Volume; Collagen; Endothelin-1; Female; Growth Substances; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Insulin-Like Growth Factor I; Male; RNA, Messenger; Swine	2004
Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicology and applied pharmacology, 2003, Dec-01, Volume: 193, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Captopril; Disease Models, Animal; Echocardiography; Endothelin-1; Genetic Markers; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Receptors, Aryl Hydrocarbon; RNA, Messenger; Ventricular Myosins	2003
Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Constriction; Coronary Vessels; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Male; Myocardium; Peptidyl-Dipeptidase A; Pressure; Rats; Rats, Wistar; Tetrazoles	2004
Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2004, Volume: 286, Issue:6 Topics: Adrenomedullin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Echocardiography; Heart; Heart Rate; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Norepinephrine; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Proteins; Receptor, Angiotensin, Type 1; Receptors, Adrenomedullin; Receptors, Peptide; Reverse Transcriptase Polymerase Chain Reaction; Telemetry; Vasoconstrictor Agents; Vasodilator Agents	2004
Angiotensin AT2 receptor: the younger sibling attracts attention. Cardiovascular research, 2004, Apr-01, Volume: 62, Issue:1 Topics: Action Potentials; Angiotensin II; Animals; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardium; Receptor, Angiotensin, Type 2	2004
Relationship between hypertensive left ventricular hypertrophy, neurohormonal factors and ventricular arrhythmias in very old patients. Acta cardiologica, 2004, Volume: 59, Issue:1 Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Biomarkers; Coronary Angiography; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin; Male; Neurotransmitter Agents; Renin	2004
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circulation research, 2004, May-14, Volume: 94, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olmesartan Medoxomil; Pilot Projects; Radiation Chimera; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Superoxide Dismutase; Tetrazoles; Up-Regulation	2004
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease. Journal of hypertension, 2004, Volume: 22, Issue:3 Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Chemokine CCL2; Down-Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Macrophages; Myocardial Contraction; Myocardium; Rats; Rats, Inbred SHR; RNA, Messenger; Thiophenes; Ultrasonography; Vasculitis	2004
Cardiac angiotensin AT2 receptor: what exactly does it do? Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6 Topics: Angiotensin II; Animals; Fibrosis; Genetic Predisposition to Disease; Humans; Hypertrophy, Left Ventricular; Introns; Mice; Mice, Knockout; Myocardium; Phosphoprotein Phosphatases; Polymorphism, Genetic; Prospective Studies; Rats; Receptor, Angiotensin, Type 2; Ventricular Remodeling	2004
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Cell Size; Eplerenone; Fibrosis; Heart Rate; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Osteopontin; Reverse Transcriptase Polymerase Chain Reaction; Sialoglycoproteins; Spironolactone; Ultrasonography; Ventricular Remodeling	2004
Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. Journal of hypertension, 2004, Volume: 22, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta; Aspirin; Body Weight; Cells, Cultured; Hypertension; Hypertrophy, Left Ventricular; Losartan; Luminescent Measurements; Male; Muscle, Smooth, Vascular; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Time Factors; Vasoconstrictor Agents	2004
Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium. Medical hypotheses, 2004, Volume: 62, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Bufanolides; Endothelium, Vascular; Humans; Hypertension; Hypertrophy, Left Ventricular; Microcirculation; Models, Biological; Models, Theoretical; Nitric Oxide; Sodium Chloride, Dietary; Vasoconstrictor Agents	2004
Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload. Journal of hypertension, 2004, Volume: 22, Issue:6 Topics: Adrenomedullin; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Diabetes Mellitus, Experimental; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Up-Regulation	2004
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling	2004
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circulation research, 2004, Sep-03, Volume: 95, Issue:5 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiac Output, Low; Cardiomyopathies; Collagenases; Disease Progression; Enzyme Precursors; Extracellular Matrix; Gelatinases; Gene Expression; Gene Expression Profiling; Genetic Predisposition to Disease; Heart Rupture; Humans; Hypertension; Hypertrophy, Left Ventricular; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Stroke Volume; Thrombospondins; Up-Regulation	2004
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. Journal of molecular medicine (Berlin, Germany), 2004, Volume: 82, Issue:10 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Collagen Type I; Disease Models, Animal; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Heart Failure; Homozygote; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Myocardium; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Smad Proteins; Tetrazoles; Time Factors; Trans-Activators; Tyrphostins	2004
Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiological genomics, 2004, Nov-17, Volume: 19, Issue:3 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hypertension; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Lentivirus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2	2004
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3. Circulation, 2004, Nov-09, Volume: 110, Issue:19 Topics: Activin Receptors, Type I; Angiotensin II; Animals; Animals, Genetically Modified; Binding, Competitive; Collagen; DNA-Binding Proteins; DNA, Complementary; Fibrosis; Humans; Hypertrophy, Left Ventricular; Myocardium; Oligopeptides; Peptidyl-Dipeptidase A; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Substrate Specificity; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:2 Topics: Acetates; Administration, Oral; Angiotensin II; Animals; Antigens, Differentiation; Aorta; Aortic Diseases; Blood Pressure; Chemokine CCL2; Collagen Type I; Collagen Type III; Drug Evaluation, Preclinical; Fibronectins; Fibrosis; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Heart; Hypertrophy, Left Ventricular; Indoleacetic Acids; Indoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nephrectomy; Osteopontin; Plasminogen Activator Inhibitor 1; Random Allocation; RNA, Messenger; Sialoglycoproteins; Single-Blind Method; Sodium Chloride, Dietary	2005
Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium. Medical hypotheses, 2005, Volume: 64, Issue:4 Topics: Angiotensin II; Bufanolides; Coronary Vessels; Endothelium, Vascular; Humans; Hypertrophy, Left Ventricular; Nitric Oxide; Sodium Chloride, Dietary; Up-Regulation	2005
Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats. Molecular and cellular biochemistry, 2005, Volume: 269, Issue:1-2 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Ciliary Neurotrophic Factor; Cytokines; Female; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Interleukin-6; Leukemia Inhibitory Factor; Male; Organ Size; Proteins; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Up-Regulation	2005
Determinants of hypertension-related cardiac organ damage: beyond the haemodynamic overload. Journal of hypertension, 2005, Volume: 23, Issue:5 Topics: Angiotensin II; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Sympathetic Nervous System	2005
Angiotensin II and norepinephrine release: interaction and effects on the heart. Journal of hypertension, 2005, Volume: 23, Issue:5 Topics: Adult; Aged; Angiotensin II; Female; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Norepinephrine; Sympathetic Nervous System	2005
Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:5 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Blood Pressure; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left	2005
Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovascular research, 2005, Sep-01, Volume: 67, Issue:4 Topics: Angiotensin II; Animals; Chemokine CCL5; Dose-Response Relationship, Drug; Echocardiography; Electrophoretic Mobility Shift Assay; Hypertrophy, Left Ventricular; Immunohistochemistry; Infusions, Intravenous; Male; MAP Kinase Kinase 4; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Models, Animal; Myocardium; NF-kappa B; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2005
Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes. Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:7 Topics: Angiotensin II; Animals; Antioxidants; Diabetes Mellitus, Experimental; Heart Ventricles; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Insulin; Male; Oxidative Stress; Rats; Rats, Wistar	2005
[Effect of tianma gouteng recipe on interfering LV and aortic hypertrophy in renovascular hypertension rats]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2005, Volume: 30, Issue:8 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Drug Combinations; Drugs, Chinese Herbal; Enalapril; Gastrodia; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Plants, Medicinal; Random Allocation; Rats; Rats, Wistar; Uncaria	2005
Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicology and applied pharmacology, 2006, Apr-15, Volume: 212, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Progression; Echocardiography; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Organ Size; Peptides, Cyclic; Receptor, Endothelin A; Receptors, Aryl Hydrocarbon; RNA, Messenger	2006
Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism. Life sciences, 2006, Feb-28, Volume: 78, Issue:14 Topics: Angiotensin I; Angiotensin II; Animals; Female; Genotype; Hypertension; Hypertrophy, Left Ventricular; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Rats; Rats, Inbred Lew; Rats, Mutant Strains	2006
[Study of effects of drugs on myocardial hypertrophy due to overload]. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2005, Volume: 17, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbazoles; Disease Models, Animal; Endothelin-1; Hypertrophy, Left Ventricular; Imidazolidines; Myocardium; Propanolamines; Random Allocation; Rats; Tumor Necrosis Factor-alpha	2005
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:1 Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Chemokine CCL2; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Membrane Glycoproteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Osmolar Concentration; Rats; Rats, Inbred Dahl; Renin; RNA, Messenger; Scavenger Receptors, Class E; Sodium Chloride, Dietary; Systole; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2006
Cardiac consequences of aldosterone excess in human hypertension. American journal of hypertension, 2006, Volume: 19, Issue:1 Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cardiovascular System; Clinical Trials as Topic; Endomyocardial Fibrosis; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Longitudinal Studies; Renin-Angiotensin System; Retrospective Studies	2006
Role of aldosterone in left ventricular hypertrophy in hypertension. American journal of hypertension, 2006, Volume: 19, Issue:1 Topics: Adrenergic beta-Antagonists; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Echocardiography; Endomyocardial Fibrosis; Female; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Middle Aged; Proteinuria; Renin-Angiotensin System	2006
Distinct modulation of angiotensin II-induced early left ventricular hypertrophic gene programming by dietary fat type. Journal of lipid research, 2006, Volume: 47, Issue:6 Topics: Angiotensin II; Animals; Blotting, Northern; Blotting, Western; Dietary Fats; Electrophoretic Mobility Shift Assay; Gene Expression; Heart Ventricles; Hypertrophy, Left Ventricular; JNK Mitogen-Activated Protein Kinases; Lipids; Male; Mitogen-Activated Protein Kinases; Models, Biological; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger	2006
Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Bradykinin; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Fibrosis; Hypertrophy, Left Ventricular; In Vitro Techniques; Lipid Peroxides; Male; Myocytes, Cardiac; Nitrates; Nitrites; Probucol; Serotonin; Superoxide Dismutase; Swine; Vasodilation	2006
Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:9 Topics: Angiotensin II; Animals; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Male; Monocrotaline; Natriuretic Peptide, Brain; Norepinephrine; Prognosis; Rats; Rats, Wistar; Up-Regulation; Ventricular Remodeling	2006
[Study of Huoxue Qianyang granules in revising the left ventricular hypertrophy of spontaneous hypertension rats]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2006, Volume: 4, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Drugs, Chinese Herbal; Heart; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Peptidyl-Dipeptidase A; Phytotherapy; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2006
The role of angiotensin receptor-1 blockade on electromechanical changes induced by left ventricular hypertrophy and its regression. Cardiovascular research, 2007, Feb-01, Volume: 73, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Constriction; Electrocardiography; Guinea Pigs; Heart; Hypertrophy, Left Ventricular; Losartan; Male; Models, Animal; Time Factors	2007
Angiotensin in the kidney: a key to understanding hypertension? Cell metabolism, 2007, Volume: 5, Issue:1 Topics: Angiotensin II; Animals; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Transplantation; Mice; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1	2007
Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats. American journal of hypertension, 2007, Volume: 20, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Extracellular Signal-Regulated MAP Kinases; Female; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Arteries; Myosin Light Chains; Phosphorylation; ras Proteins; Rats; Rats, Inbred SHR	2007
Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo. Life sciences, 2007, Mar-13, Volume: 80, Issue:14 Topics: Adrenalectomy; Angiotensin II; Animals; Atrial Natriuretic Factor; Blotting, Northern; Cardenolides; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Norepinephrine; Organ Size; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saponins; Up-Regulation; Vasoconstrictor Agents	2007
Cardiac BNP gene activation by angiotensin II in vivo. Molecular and cellular endocrinology, 2007, Jul-15, Volume: 273, Issue:1-2 Topics: Angiotensin II; Animals; Body Weight; Cells, Cultured; DNA; GATA4 Transcription Factor; GATA6 Transcription Factor; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; Organ Size; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-ets; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation	2007
[Influence of daidzein on left ventricular remodeling in rats with hypertrophic myocardium induced by pressure overload]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2007, Volume: 32, Issue:14 Topics: Angiotensin II; Animals; Hypertrophy, Left Ventricular; Isoflavones; Male; Myocardium; Nitric Oxide; Phytoestrogens; Random Allocation; Rats; Rats, Wistar; Ventricular Remodeling	2007
Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circulation research, 2008, Jan-04, Volume: 102, Issue:1 Topics: Angiotensin II; Animals; Cardiotonic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Oxidative Stress; Quinolines; Renal Insufficiency; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ventricular Remodeling	2008
[Influnce of Tinglizi on some neuroendocrine factors and type I and III collagen in ventricular remodeling induced by abdominal aortic banding in rats]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2007, Volume: 30, Issue:8 Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Collagen; Constriction; Drugs, Chinese Herbal; Endothelins; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Seeds; Ventricular Remodeling	2007
Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis. British journal of pharmacology, 2008, Volume: 153, Issue:4 Topics: Adaptation, Physiological; Angiotensin II; Animals; Aorta; Blood Pressure; Cytokines; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Genotype; Hypertrophy, Left Ventricular; Inflammation; Intercellular Signaling Peptides and Proteins; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Phenotype; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Signal Transduction; Time Factors; Ventricular Function, Left	2008
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice. Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure, Diastolic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Pravastatin; rho-Associated Kinases; Ventricular Remodeling	2008
Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circulation research, 2008, Mar-28, Volume: 102, Issue:6 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Calcium-Binding Proteins; Calpain; Cysteine Proteinase Inhibitors; Disease Models, Animal; Fibrosis; Genetic Therapy; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Inflammation; Infusion Pumps, Implantable; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Myocardium; NF-kappa B; NFATC Transcription Factors; Renal Artery; Time Factors; Ventricular Remodeling	2008
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovascular research, 2008, Jun-01, Volume: 78, Issue:3 Topics: Angiogenic Proteins; Angiotensin II; Animals; Aorta, Thoracic; Apoptosis; Blotting, Western; Constriction; Disease Models, Animal; Disease Progression; Energy Metabolism; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Mechanotransduction, Cellular; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Neovascularization, Physiologic; Phosphorylation; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical; Ventricular Function, Left; Ventricular Remodeling	2008
Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Linkage Disequilibrium; Male; Mice; Mice, Inbred C57BL; Middle Aged; Muscle Proteins; Myocytes, Cardiac; Polymorphism, Single Nucleotide; Rats; Rats, Sprague-Dawley; Ultrasonography; Vasoconstrictor Agents	2007
AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:2 Topics: Adaptation, Physiological; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Body Weight; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hemodynamics; Hypertrophy, Left Ventricular; Losartan; Male; Muscle Strength; Myocardium; Physical Exertion; Polymerase Chain Reaction; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary; Up-Regulation	2008
Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin. European journal of pharmacology, 1995, Jun-23, Volume: 280, Issue:1 Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Azepines; Biphenyl Compounds; Cardiac Volume; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Imidazoles; Indoles; Losartan; Male; Molecular Sequence Data; Myocardium; Organ Size; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Time Factors	1995
Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. American heart journal, 1995, Volume: 129, Issue:5 Topics: Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Fibroblast Growth Factor 2; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Male; Myocardial Ischemia; Neovascularization, Pathologic; Pericardium; Rabbits; Statistics, Nonparametric; Stimulation, Chemical	1995
Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biochemical Phenomena; Biochemistry; Biphenyl Compounds; Cardiomyopathies; Collagen; Endomyocardial Fibrosis; Fibrosis; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Microscopy, Polarization; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Spironolactone; Tetrazoles	1995
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade. Circulation research, 1995, Volume: 76, Issue:5 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Body Weight; Captopril; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Organ Size; Rats; Rats, Inbred SHR; Tetrazoles	1995
[Effects of angiotensin II on spontaneous cytosolic calcium releases in ventricular myocytes of adult normal and hypertensive rats]. Archives des maladies du coeur et des vaisseaux, 1994, Volume: 87, Issue:8 Topics: Angiotensin II; Animals; Calcium; Cytosol; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Sprague-Dawley	1994
Central action of basic fibroblast growth factor on ingestive behaviour in mice. Physiology & behavior, 1995, Volume: 57, Issue:4 Topics: Angiotensin II; Animals; Body Weight; Drinking; Eating; Fibroblast Growth Factor 2; Humans; Hypertrophy, Left Ventricular; Injections, Intraventricular; Male; Mice; Mice, Inbred BALB C; Recombinant Proteins; Sodium; Water Deprivation	1995
Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM. Diabetologia, 1995, Volume: 38, Issue:4 Topics: Adult; Aged; Albuminuria; Angiotensin II; Antiporters; Blood Pressure; Body Mass Index; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Doppler, Pulsed; Epinephrine; Erythrocytes; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertrophy, Left Ventricular; Insulin; Lithium; Male; Middle Aged; Norepinephrine; Regression Analysis; Sodium	1995
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation, 1994, Volume: 89, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Signal Transduction; Tetrazoles	1994
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation, 1994, Volume: 89, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Enalapril; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors	1994
TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Life sciences, 1994, Volume: 54, Issue:25 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Heart Atria; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR; Renin; Tetrazoles	1994
Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels. The American journal of cardiology, 1993, Jun-24, Volume: 71, Issue:17 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR	1993
Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. Journal of molecular and cellular cardiology, 1993, Volume: 25, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Heart; Hydroxyproline; Hyperaldosteronism; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Sprague-Dawley	1993
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation, 1993, Volume: 87, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptides; Enalaprilat; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Up-Regulation; Ventricular Function, Left	1993
The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats. Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Renal; Hypertrophy, Left Ventricular; Indoles; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Radioimmunoassay; Rats; Rats, Wistar; Renin; Sodium Chloride	1993
Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Fructose; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Tetrazoles	1993
Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation, 1995, Dec-15, Volume: 92, Issue:12 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hypertrophy, Left Ventricular; Isoquinolines; Male; Myocardium; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Pressure	1995
Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation, 1996, Mar-15, Volume: 93, Issue:6 Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Body Weight; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Peptidyl-Dipeptidase A; Regression Analysis; Renin; Renin-Angiotensin System	1996
Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. The Journal of clinical investigation, 1995, Volume: 96, Issue:6 Topics: Angiotensin II; Animals; Aorta; Gene Expression; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Kinetics; Male; Myocardium; Norepinephrine; Organ Size; Perfusion; Phenylalanine; Prazosin; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; Rats; Rats, Wistar; Reference Values; Systole; Time Factors	1995
Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives. American journal of hypertension, 1996, Volume: 9, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Catecholamines; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Radioimmunoassay	1996
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 28, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Heart Ventricles; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Myosin Heavy Chains; Organ Size; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles	1996
Angiotensin II receptor gene expression in hypertrophied left ventricles of rat hearts. Journal of hypertension, 1996, Volume: 14, Issue:3 Topics: Angiotensin II; Animals; Base Sequence; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Molecular Sequence Data; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger	1996
[Heart hypertrophy. Determinant factors and molecular mechanisms]. Arquivos brasileiros de cardiologia, 1995, Volume: 65, Issue:6 Topics: Adult; Age Factors; Aged; Angiotensin II; Cardiomegaly; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Racial Groups; Risk Factors; Sex Factors; Thyroid Hormones	1995
Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. Journal of hypertension, 1996, Volume: 14, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles	1996
Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation, 1996, Sep-15, Volume: 94, Issue:6 Topics: Adult; Angiotensin II; Cohort Studies; Cross-Sectional Studies; Diet; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuresis; Sodium	1996
[Rational hypertension treatment]. Schweizerische medizinische Wochenschrift, 1996, Aug-17, Volume: 126, Issue:33 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Imidazoline Receptors; Male; Receptors, Drug; Vasodilator Agents	1996
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. The Journal of clinical investigation, 1996, Nov-15, Volume: 98, Issue:10 Topics: Angiotensin II; Animals; Antibodies, Blocking; Antibodies, Monoclonal; Biphenyl Compounds; Blotting, Northern; Cells, Cultured; Collagen; DNA; Fibroblasts; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Integrins; Losartan; Myocardium; Oligopeptides; Osteopontin; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Wound Healing	1996
Angiotensin II mediates mechanical stress-induced cardiac hypertrophy. Diabetes research and clinical practice, 1996, Volume: 30 Suppl Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Enzyme Activation; Heart; Hypertrophy, Left Ventricular; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardial Contraction; Myocardium; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Stress, Mechanical	1996
Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation, 1996, Dec-15, Volume: 94, Issue:12 Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Coarctation; Blood Pressure; Heart; Heart Rate; Hemodynamics; Hypertrophy, Left Ventricular; Myocardium; Rats; Rats, Wistar; Reference Values	1996
Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	1996
Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Cardiovascular research, 1997, Volume: 33, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diastole; Disease Models, Animal; Dogs; Enalaprilat; Hypertension, Renal; Hypertrophy, Left Ventricular; Imidazoles; Receptors, Angiotensin; Tetrazoles; Ventricular Function, Left	1997
Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II? Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Diabetes Mellitus, Experimental; Heart Septum; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR	1997
Baroreflex control of heart rate and cardiac hypertrophy in angiotensin II-induced hypertension in rabbits. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:6 Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Infusion Pumps; Rabbits	1997
Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart (British Cardiac Society), 1997, Volume: 77, Issue:6 Topics: Angiotensin II; Coronary Angiography; Female; Gene Deletion; Genotype; Heart; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin	1997
The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures. Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:3 Topics: Adaptation, Physiological; Angiotensin II; Animals; Atmospheric Pressure; Biphenyl Compounds; Body Weight; Decompression; Heart; Heart Function Tests; Helium; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardium; Nitrogen; Oxygen; Partial Pressure; Rats; Rats, Wistar; Tetrazoles	1997
Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension. Chinese medical journal, 1996, Volume: 109, Issue:11 Topics: Aldosterone; Angiotensin II; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Parathyroid Hormone; Renin-Angiotensin System	1996
Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Topics: Angiotensin II; Animals; Animals, Newborn; Bradykinin; Bradykinin Receptor Antagonists; Cells, Cultured; Endothelium; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley	1998
Load-sensitive diastolic relaxation in hypertrophied left ventricles. The American journal of physiology, 1998, Volume: 274, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Diastole; Dogs; Enalaprilat; Hemodynamics; Hypertension, Renal; Hypertrophy, Left Ventricular; Imidazoles; Tetrazoles	1998
Inadequate suppression of angiotensin II modulates left ventricular structure in humans. Clinical nephrology, 1998, Volume: 49, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertrophy, Left Ventricular; Male; Renin; Sodium; Sodium, Dietary	1998
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science (New York, N.Y.), 1998, Apr-24, Volume: 280, Issue:5363 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; COS Cells; Diglycerides; Enzyme Activation; Gene Expression Regulation; Gene Targeting; GTP-Binding Proteins; Hypertrophy, Left Ventricular; Inositol Phosphates; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Myocardium; Peptide Fragments; Phenylephrine; Receptors, Adrenergic, alpha; Signal Transduction; Transfection; Transgenes; Ventricular Pressure	1998
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. Journal of hypertension, 1998, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Endomyocardial Fibrosis; Estradiol; Estrone; Female; Fibroblasts; Gene Expression; Genes, fos; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Menopause; Myocardium; Rats; Sp1 Transcription Factor; Tetrahydroisoquinolines	1998
Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. Journal of hypertension, 1998, Volume: 16, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Catecholamines; Ganglionic Blockers; Heart Rate; Heart Ventricles; Hexamethonium; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium, Dietary; Sympathetic Nervous System	1998
Sodium, angiotensin II, blood pressure, and cardiac hypertrophy. Kidney international. Supplement, 1998, Volume: 67 Topics: Angiotensin II; Animals; Blood Pressure; Hypertrophy, Left Ventricular; Kidney; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium	1998
[Effect of chronic bradykinin infusion on angiotensin II hypertension in rats]. Archives des maladies du coeur et des vaisseaux, 1998, Volume: 91, Issue:8 Topics: Angiotensin II; Animals; Bradykinin; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley	1998
Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. Journal of cardiac failure, 1998, Volume: 4, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Body Weight; Diastole; Drug Therapy, Combination; Echocardiography; Female; Growth Hormone; Hemodynamics; Hypertrophy, Left Ventricular; Kidney; Liver; Losartan; Myocardial Infarction; Myocardium; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Spleen; Ventricular Function, Left; Ventricular Remodeling	1998
Effects of renin-angiotensin system blockade and dietary salt intake on left ventricular hypertrophy in Dahl salt-sensitive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 1998, Volume: 21, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diet; Hypertrophy, Left Ventricular; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Time Factors	1998
Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1996, Volume: 17, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger	1996
Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist. Clinical science (London, England : 1979), 1999, Volume: 96, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Calcium-Binding Proteins; Calcium-Transporting ATPases; Calsequestrin; Gene Expression; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tetrazoles; Ventricular Function, Left	1999
[Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors]. Biulleten' eksperimental'noi biologii i meditsiny, 1999, Volume: 127, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Rabbits; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan	1999
[Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II]. Doklady Akademii nauk, 1999, Volume: 366, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Heart Ventricles; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Organ Size; Rabbits; Tetrazoles; Valine; Valsartan	1999
Myocardial insulin resistance in cardiac hypertrophy. Cardiovascular research, 1999, Volume: 42, Issue:1 Topics: Angiotensin II; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Receptors, Angiotensin	1999
Inhibitory effects of captopril on c-myc expression during left ventricular hypertrophy. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1998, Volume: 19, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Genes, myc; Hypertension; Hypertrophy, Left Ventricular; Male; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger	1998
Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Blood Pressure; Captopril; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hypertrophy, Left Ventricular; Organ Size; Peptidyl-Dipeptidase A; Rats; Simvastatin; Time Factors	1999
Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Eating; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; RNA, Messenger	1999
Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Female; Fibrosis; Heart Failure; Heart Rate; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myocardium; Nicotinic Acids; Organ Size; Phenotype; Pregnancy; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrazoles	2000
Coronary microvascular endothelial cell redox state in left ventricular hypertrophy : the role of angiotensin II. Circulation research, 2000, Mar-03, Volume: 86, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Coronary Circulation; Cytochrome c Group; Endothelium, Vascular; Guinea Pigs; Heart Ventricles; Hypertrophy, Left Ventricular; Microcirculation; Myocardium; NAD; NADPH Oxidases; Organ Size; Oxidation-Reduction; Superoxides	2000
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Mice; Myocardium	2000
Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. The American journal of pathology, 2000, Volume: 156, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Body Weight; Cell Death; Cell Size; Cells, Cultured; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Stress, Mechanical; Time Factors; Up-Regulation	2000
Effects of perindopril on vascular wall and left ventricular hypertrophy in rats with experimental hypertension. Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1998, Volume: 18, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Artery, Superior; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley	1998
Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Aorta; Echocardiography; Hypertrophy, Left Ventricular; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Pressure	2000
Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6 Topics: Adrenomedullin; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diastole; Dihydropyridines; Gene Expression; Heart Rate; Hypertrophy, Left Ventricular; Male; Nitrobenzenes; Peptides; Piperazines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Stress, Mechanical; Tetrazoles; Vasoconstrictor Agents	2000
Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:6 Topics: Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; Caspase 3; Caspases; Cells, Cultured; Enzyme Activation; Heart; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tumor Suppressor Protein p53	2000
[What is Na+/H+ exchanger guilty of in cardiology?]. Medicina, 2000, Volume: 60, Issue:5 Pt 2 Topics: Acidosis; Angiotensin II; Animals; Bicarbonates; Calcium; Carbon Dioxide; Cell Membrane Permeability; Diabetes Mellitus; Endothelins; HEPES; Humans; Hydrogen-Ion Concentration; Hypertension; Hypertrophy, Left Ventricular; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Protons; Sodium Channels; Sodium-Hydrogen Exchangers	2000
Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats. Life sciences, 2000, Nov-17, Volume: 67, Issue:26 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Captopril; Hypertrophy, Left Ventricular; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System; Synapses; Vasoconstriction	2000
Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enzyme Activation; Gene Expression; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Rats; RNA, Messenger	2001
Load versus humoral activation in the genesis of early hypertensive heart disease. Circulation, 2001, Jul-10, Volume: 104, Issue:2 Topics: Angiotensin II; Animals; Catecholamines; Diastole; Disease Models, Animal; Dogs; Endothelin-1; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Natriuretic Peptide, Brain; Propranolol; Renin; Systole; Ventricular Dysfunction, Left	2001
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation, 2001, Jul-17, Volume: 104, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Collagen; Diastole; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Endomyocardial Fibrosis; Fibronectins; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Systole; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
[Study on changes of plasma substance P in essential hypertension with left ventricular hypertrophy patients and the effect of promoting blood circulation and eliminating phlegm]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1998, Volume: 18, Issue:6 Topics: Aged; Angiotensin II; Drugs, Chinese Herbal; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Substance P	1998
Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation, 2001, Jul-31, Volume: 104, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Progression; Endothelin-1; Endothelins; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Organ Size; Peptidyl-Dipeptidase A; Protein Precursors; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Survival Analysis; Thiazepines; Time Factors	2001
Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR. Acta pharmacologica Sinica, 2000, Volume: 21, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan	2000
Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. American journal of hypertension, 2001, Volume: 14, Issue:9 Pt 1 Topics: Aged; Angiotensin II; Biomarkers; Carotid Arteries; E-Selectin; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Intercellular Adhesion Molecule-1; Male; Middle Aged; Severity of Illness Index; Tunica Intima; Vascular Cell Adhesion Molecule-1	2001
[The sarcoplasmic reticulum Ca2+ handling protein and left ventricular hypertrophy in SHR]. Zhonghua yi xue za zhi, 1999, Volume: 79, Issue:4 Topics: Angiotensin II; Animals; Calcium-Transporting ATPases; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum	1999
Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. Journal of the American College of Cardiology, 2001, Nov-01, Volume: 38, Issue:5 Topics: Adolescent; Adult; Aged; Angiotensin II; Cardiomyopathy, Dilated; Case-Control Studies; Cytokines; Female; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Linear Models; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Predictive Value of Tests; Radioimmunoassay; Severity of Illness Index; Signal Transduction; Stroke Volume; Ventricular Remodeling	2001
[Early prevention of experimental left ventricular hypertrophy in experimental hypertension and angiotensin II levels]. Revista espanola de cardiologia, 2001, Volume: 54, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Drug Evaluation, Preclinical; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley	2001
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circulation research, 2001, Nov-23, Volume: 89, Issue:11 Topics: Adult; Angiotensin II; Echocardiography; Exercise; Heart; Humans; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardium; Norepinephrine; Soccer; Sympathetic Nervous System	2001
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats. International journal of cardiology, 2001, Volume: 81, Issue:2-3 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1	2001
[Changes of myocardial tissue and plasma angiotensin II in rats with pressure overload and effect of lujiao prescription]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2000, Volume: 20, Issue:4 Topics: Angiotensin II; Animals; Aorta, Abdominal; Constriction, Pathologic; Drugs, Chinese Herbal; Heart Failure; Hypertrophy, Left Ventricular; Male; Myocardium; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System	2000
[Study on the relation between hypertensive left ventricular hypertrophy in very old people with neurohormonal factors and ventricular arrhythmias]. Zhonghua nei ke za zhi, 2000, Volume: 39, Issue:12 Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Myocardial Ischemia; Renin	2000
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. American journal of hypertension, 2002, Volume: 15, Issue:1 Pt 1 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles	2002
Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Cardiovascular research, 2002, Feb-01, Volume: 53, Issue:2 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Aspartic Acid Endopeptidases; Collagen; Endothelin-1; Endothelin-Converting Enzymes; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Metalloendopeptidases; Models, Animal; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2002
Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist. Journal of cardiac failure, 2002, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Female; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Time Factors	2002
Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle. American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 282, Issue:5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Valve Stenosis; Atrial Natriuretic Factor; Endothelin Receptor Antagonists; Endothelins; Female; Gene Expression; Hydralazine; Hypertrophy, Left Ventricular; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A	2002
Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload. Biochimica et biophysica acta, 2002, Apr-24, Volume: 1586, Issue:3 Topics: Angiotensin II; Animals; Apoptosis; Cell Cycle; Disease Models, Animal; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Myocardium; Pressure; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2002